Vaccine Safety-Related Articles

Td/DTaP/Tdap

Apr 2013

Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis. 2013 Mar 26;13(1):151. [Epub ahead of print].
Clarke C, Wall GC, Soltis DA. An introductory pharmacy practice experience to improve pertussis immunization rates in mothers of newborns. Am J Pharm Educ. 2013 Mar 12;77(2):29.
Dbaibo G, El-Ayoubi N, Ghanem S, Hajar F, Bianco V, Miller JM, Mesaros N. Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56Years and Older: Results of an Open-Label, Randomized, Controlled Trial. Drugs Aging. 2013 Mar 14. [Epub ahead of print].
Fowkes FJ, McGready R, Johnstone-Robertson S, Nosten F, Beeson JG. Antibody boosting and longevity following tetanus immunization during pregnancy. Clin Infect Dis. 2013 Mar; 56(5):749-50.
Witt MA, Arias L, Katz PH, Truong ET, Witt DJ. Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort. Clin Infect Dis. 2013 Mar 13. [Epub ahead of print].

Mar 2013

Waning protection from acellular pertussis vaccine. J Paediatr Child Health. 2013 Feb;49(2):157.
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013 Feb 22;62:131-5.
Chang S, O'Connor PM, Slade BA, Woo EJ. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007. Vaccine. 2013 Feb 27;31(10):1447-52.
Esolen LM, Kilheeney KL. A mandatory campaign to vaccinate health care workers against pertussis. Am J Infect Control. 2013 Feb 5. [Epub ahead of print].
Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (tdap) immunization and protection of young infants. Clin Infect Dis. 2013 Feb;56(4):539-44.
Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med. 2013 Feb 7; 368(6):581-2.
Meregaglia M, Ferrara L, Melegaro A, Demicheli V. Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: The case of Piemonte in Italy. Vaccine. 2013 Feb 6; 31(8):1135-7.
Nitsch-Osuch A, Korzeniewski K, Kuchar E, Zielonka T, Zycińska K, Wardyn K. Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults. Respir Physiol Neurobiol. 2013 Feb 15. [Epub ahead of print].
Riley LE, Beigi RH. Editorial commentary: maternal pertussis vaccination: protecting neonates from infection. Clin Infect Dis. 2013 Feb;56(4):545-7.
Scott LJ, McCormack PL. Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine, adsorbed (boostrix(®)) : a guide to its use as a single-dose booster immunization against pertussis. BioDrugs. 2013 Feb;27(1):75-81.
Serinken M, Gozlukaya A, Sari I, Karcioglu O. Thrombocytopenia after tetanus prophylaxis with tetanus-diphtheria (td) vaccine. J Emerg Med. 2013 Feb; 44(2):e287-8.
Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ; Vaccine Safety Datalink (VSD) Team. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013 Feb; 56(3):315-21.
Vermeulen F, Dirix V, Verscheure V, Damis E, Vermeylen D, Locht C, Mascart F. Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose. Vaccine. 2013 Feb 18. [Epub ahead of print].
Wiedermann BL. What's Wrong With Acellular Pertussis Vaccines? Clin Ther. 2013 Feb;35(2):115-8.
Zarei S, Jeddi-Tehrani M, Mehdi Akhondi M, Zeraati H, Ferydonfar AA, Nasernia J, Tavangar B, Shokri F. Immunogenicity and reactogenicity of two diphtheria-tetanus-whole cell pertussis vaccines in Iranian pre-school children, a randomized controlled trial. Hum Vaccin Immunother. 2013 Feb 26; 9(6). [Epub ahead of print].

Feb 2013

Dias WO, van der Ark AA, Sakauchi MA, Kubrusly FS, Prestes AF, Borges MM, Furuyama N, Horton DS, Quintilio W, Antoniazi M, Kuipers B, van der Zeijst BA, Raw I. An improved whole cell pertussis vaccine with reduced content of endotoxin. Hum Vaccin Immunother. 2013 Jan 4;9(2). [Epub ahead of print].
Gopal R, Rangel-Moreno J, Slight S, Lin Y, Nawar HF, Fallert Junecko BA, Reinhart TA, Kolls J, Randall TD, Connell TD, Khader SA. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 2013 Jan 9. [Epub ahead of print]
Khatami A, Snape MD, Ohene-Kena B, Young K, Oeser C, Michaelis LJ, Macleod E, Smee H, Van Der Meeren O, Leyssen M, Caubet M, Yu LM, Heath PT, Faust SN, Finn A, Pollard AJ. Phase II Study of a Three-Dose Primary Vaccination Course of DTPa-IPV/Hib-MenC-TT Followed by a 12-Month Hib-MenC-TT Booster in Healthy Infants. Pediatr Infect Dis J. 2013 Jan 23. [Epub ahead of print]
Livingston KA, Jiang X, Stephensen CB. CD4 T-helper cell cytokine phenotypes and antibody response following tetanus toxoid booster immunization. J Immunol Methods. 2013 Jan 11. [Epub ahead of print].
Meregaglia M, Ferrara L, Melegaro A, Demicheli V. Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: The case of Piemonte in Italy. Vaccine. 2013 Jan 7. [Epub ahead of print].
Nitsch-Osuch A, Kuchar E, Modrzejewska G, Pirogowicz I, Zycinska K, Wardyn K. Epidemiology of pertussis in an urban region of Poland: time for a booster for adolescents and adults. Adv Exp Med Biol. 2013;755:203-12.
Prelog M, Almanzar G, Rieber N, Ottensmeier B, Zlamy M, Liese J. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine. 2013 Jan 2; 31(2):387-93.
Shankar AG, Lee A, Reddy H, Seymour M. Bordetella pertussis infection in a child with completed primary immunization: A case report. Hum Vaccin Immunother. 2013 Jan 4; 9(2). [Epub ahead of print]
Wójcik OP, Simonsen J, Mølbak K, Valentiner-Branth P. Validation of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish childhood vaccination database. Vaccine. 2013 Jan 30; 31(6):955-9.

Aug 2012

Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations. Vaccine. 2012 Jul 27; 30(35):5179-90.
Hope K, Butler M, Massey PD, Cashman P, Durrheim DN, Stephenson J, Worley A. Pertussis vaccination in Child Care Workers: room for improvement in coverage, policy and practice. BMC Pediatr. 2012 Jul 13; 12(1):98. [Epub ahead of print].
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M, Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J. 2012 Jul 23. [Epub ahead of print].
Thierry-Carstensen B, Jordan K, Uhlving HH, Dalby T, Sørensen C, Jensen AM, Heilmann C. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 2012 Aug 10; 30(37):5464-71.
Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, Tokars JI, Vellozzi C, Broder KR. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol. 2012 Jul; 207(1):59.e1-7.

Jul 2012

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2012 Jun 29; 61:468-70.
Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations. Vaccine. 2012 Jun 15. [Epub ahead of print].
Benn CS, Aaby P. Diphtheria-Tetanus-Pertussis Vaccination Administered After Measles Vaccine: Increased Female Mortality? Pediatr Infect Dis J. 2012 Jun 7. [Epub ahead of print].
Bottero D, Gaillard ME, Basile LA, Fritz M, Hozbor DF. Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America. J Appl Microbiol. 2012 Jun; 112(6):1266-76.
Kwak GY, Kwon HJ, Kim JH, Kim HM, Park JS, Ma SH, Kim JG, Kang JH. The immunogenicity and safety of DTaP interchangeable immunization among Korean children. Vaccine. 2012 Jun 29; 30(31):4644-7.
Lodolce AE. Shortened interval between tetanus vaccines. Ann Pharmacother. 2012 Jun; 46(6):884 8.
Mughal A, Kazi YF, Bukhari HA, Ali M. Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan. Public Health. 2012 Jun; 126(6):518-22.
Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML. Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection? Clin Vaccine Immunol. 2012 Jun; 19(6):875-80.
Rozhnova G, Nunes A. Modelling the long-term dynamics of pre-vaccination pertussis. J R Soc Interface. 2012 Jun 20. [Epub ahead of print].
Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a north American outbreak. Clin Infect Dis. 2012 Jun; 54(12):1730-5.

Jun 2012

Validation of maternal and neonatal tetanus elimination in Liberia, 2011. Wkly Epidemiol Rec. 2012 May 4; 87(18):169-76. English, French.
Kwak GY, Kwon HJ, Kim JH, Kim HM, Park JS, Ma SH, Kim JG, Kang JH. The immunogenicity and safety of DTaP interchangeable immunization among Korean children. Vaccine. 2012 May 10. [Epub ahead of print].
Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, Phoon MC, Chow VT. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine. 2012 May 21; 30(24):3566-71.
Locht C, Mielcarek N. New pertussis vaccination approaches: en route to protect newborns? FEMS Immunol Med Microbiol. 2012 May 10. [Epub ahead of print].
Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance. Vaccine. 2012 May 2; 30(21):3239-47.
Yoon YH, Moon SW, Choi SH, Cho YD, Kim JY, Kwak YH. Clinician awareness of tetanus-diphtheria vaccination in trauma patients: a questionnaire study. Scand J Trauma Resusc Emerg Med. 2012 May 15; 20(1):35. [Epub ahead of print].

May 2012

Fortner KB, Kuller JA, Rhee EJ, Edwards KM. Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy. Obstet Gynecol Surv. 2012 Apr; 67(4):251-7.
Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR. A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel. Clin Infect Dis. 2012 Apr; 54(7):938-45.
Gröndahl-Yli-Hannuksela K, Vuononvirta J, Barkoff AM, Viander M, Van Der Meeren O, Mertsola J, He Q. Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence. J Infect Dis. 2012 Apr; 205(8):1214-9.
Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, Phoon MC, Chow VT. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine. 2012 Apr 1. [Epub ahead of print].
Pawloski LC, Kirkland KB, Baughman AL, Martin MD, Talbot EA, Messonnier NE, Tondella ML. Does Tdap Vaccination Interfere with Serodiagnosis of Pertussis Infection? Clin Vaccine Immunol. 2012 Apr 25. [Epub ahead of print].
Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early Impact of the US Tdap Vaccination Program on Pertussis Trends. Arch Pediatr Adolesc Med. 2012 Apr; 166(4):344-9.

Apr 2012

Committee on Obstetric Practice. ACOG Committee Opinion No. 521: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2012 Mar; 119(3):690-1.
Ferrera G, Cuccia M, Mereu G, Icardi G, Bona G, Esposito S, Federico M, Messier M, Kuriyakose S, Hardt K. Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2+1 schedule in infancy. Hum Vaccin Immunother. 2012 Mar 1; 8(3). [Epub ahead of print].
Gröndahl-Yli-Hannuksela K, Vuononvirta J, Barkoff AM, Viander M, Van Der Meeren O, Mertsola J, He Q. Gene Polymorphism in Toll-like Receptor 4: Effect on Antibody Production and Persistence After Acellular Pertussis Vaccination During Adolescence. J Infect Dis. 2012 Apr; 205(8):1214-9.
Mughal A, Kazi YF, Bukhari HA, Ali M. Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan. Public Health. 2012 Mar 23. [Epub ahead of print].
Tomovici A, Barreto L, Zickler P, Meekison W, Noya F, Voloshen T, Lavigne P. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012 Mar 30; 30(16):2647-53.
Witt MA, Katz PH, Witt DJ. Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Pre-Adolescents in a North American Outbreak. Clin Infect Dis. 2012 Mar 15. [Epub ahead of print].

Mar 2012

Aaby P, Ravn H, Roth A, Rodrigues A, Lisse IM, Diness BR, Lausch KR, Lund N, Rasmussen J, Biering-Sørensen S, Whittle H, Benn CS. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child. 2012 Feb 13. [Epub ahead of print].
Aboal Beato MÁ, Martínez Suárez M, Castrillón Piñeiro LM, Juncal Fondevila AR. Protective tetanus antibody titres and new re-vaccination requirements. Aten Primaria. 2012 Feb; 44(2):e1-2.
Girard DZ. Recommended or mandatory pertussis vaccination policy in developed countries: Does the choice matter? Public Health. 2012 Feb; 126(2):117-22.
Langley JM, Halperin SA, Rubin E, White C, McNeil S, Mutch J, Mackinnon-Cameron D, Smith B. Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial. Pediatr Infect Dis J. 2012 Feb; 31(2):189-92.
Millier A, Aballea S, Annemans L, Toumi M, Quilici S. A critical literature review of health economic evaluations in pertussis booster vaccination. ExpertRev Pharmacoecon Outcomes Res. 2012 Feb; 12(1):71-94.
Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis. 2012 Feb 1; 54(3):318-27.
Sun Y, Christensen J, Hviid A, Li J, Vedsted P, Olsen J, Vestergaard M. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.JAMA. 2012 Feb 22; 307(8):823-31.
Tomovici A, Barreto L, Zickler P, Meekison W, Noya F, Voloshen T, Lavigne P. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012 Feb 18. [Epub ahead of print].

Feb 2012

Camenga DR, Kyanko K, Stepczynski J, Flaherty-Hewitt M, Curry L, Sewell D, Smart C, Rosenthal MS. Increasing adult tdap vaccination rates by vaccinating infant caregivers in the pediatric office. Acad Pediatr. 2012 Jan; 12(1):20-5.
Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012 Jan; 54(1):78-84.
Girard DZ. Recommended or mandatory pertussis vaccination policy in developed countries: Does the choice matter? Public Health. 2012 Jan 4. [Epub ahead of print].
Goins WP, Edwards KM, Vnencak-Jones CL, Rock MT, Swift M, Thayer V, Schaffner W, Talbot TR. A Comparison of 2 Strategies to Prevent Infection Following Pertussis Exposure in Vaccinated Healthcare Personnel. Clin Infect Dis. 2012 Jan 11. [Epub ahead of print].
Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early Impact of the US Tdap Vaccination Program on Pertussis Trends. Arch Pediatr Adolesc Med. 2012 Jan 11. [Epub ahead of print].
Weber DJ, Consoli SA, Sickbert-Bennett E, Rutala WA. Assessment of a mandatory tetanus, diphtheria, and pertussis vaccination requirement on vaccine uptake over time. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):81-3.

Jan 2012

Hendrikx LH, Felderhof MK, Oztürk K, de Rond LG, van Houten MA, Sanders EA, Berbers GA, Buisman AM. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age. Vaccine. 2011 Dec 9; 30(1):51-8.
Langley JM, Halperin SA, Rubin E, White C, Macneil S, Mutch J, Mackinnon-Cameron D, Smith B. Safety and Immunogenicity of Two Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age: A Randomized Controlled Trial. Pediatr Infect Dis J. 2011 Dec 14. [Epub ahead of print].
Miller BL, Ahmed F, Lindley MC, Wortley PM. US hospital requirements for pertussis vaccination of healthcare personnel, 2011. Infect Control Hosp Epidemiol. 2011 Dec; 32(12):1209-12.
Skowronski DM, Janjua NZ, Sonfack Tsafack EP, Ouakki M, Hoang L, De Serres G. The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization. Clin Infect Dis. 2011 Dec 8. [Epub ahead of print].
Vic P, Puech J. Health care workers' knowledge and vaccination coverage against pertussis in a French pediatric and maternity ward. Arch Pediatr. 2011 Dec; 18(12):1334-5.
Weber DJ, Consoli SA, Sickbert-Bennett E, Rutala WA. Assessment of a Mandatory Tetanus, Diphtheria, and Pertussis Vaccination Requirement on Vaccine Uptake over Time. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):81-3.

Dec 2011

Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection. Clin Infect Dis. 2011 Nov 10. [Epub ahead of print].
Hallander HO, Nilsson L, Gustafsson L. Is adolescent pertussis vaccination preferable to natural booster infections? Expert Rev Clin Pharmacol. 2011 Nov; 4(6):705-11.
Hendrikx LH, Felderhof MK, Oztürk K, de Rond LG, van Houten MA, Sanders EA, Berbers GA, Buisman AM. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age. Vaccine. 2011 Nov 4. [Epub ahead of print].
Hendrikx LH, Oztürk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM. Serum IgA Responses against Pertussis Proteins in Infected and Dutch wP or aP Vaccinated Children: An Additional Role in Pertussis Diagnostics. PLoS One. 2011; 6(11):e27681.
Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q, Zeng TD, Liu TX, Li XB, Huang YN, Deng ML, Zhang YP, Ortiz E. Antibody persistence at 18-20months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China. Vaccine. 2011 Nov 21; 29(50):9337-44.
Nilsson L, Lepp T, von Segebaden K, Hallander H, Gustafsson L. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance. Vaccine. 2011 Nov 14. [Epub ahead of print].
Rozenbaum MH, De Vries R, LE HH, Postma MJ. Modelling the impact of extended vaccination strategies on the epidemiology of pertussis. Epidemiol Infect. 2011 Nov 24:1-12. [Epub ahead of print].
Weston W, Messier M, Friedland LR, Wu X, Howe B. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine. Vaccine. 2011 Nov 3; 29(47):8483-6.

Nov 2011

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months --- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011 Oct 21; 60:1424-6.
Kusek L. Tdap vaccination strategies for health care personnel. J Nurs Care Qual. 2011 Oct-Dec; 26(4):287-91.
Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q, Zeng TD, Liu TX, Li XB, Huang YN, Deng ML, Zhang YP, Ortiz E. Antibody persistence at 18-20months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China. Vaccine. 2011 Oct 14. [Epub ahead of print].
Vic P, Puech J. Health care workers' knowledge and vaccination coverage against pertussis in a French pediatric and maternity ward. Arch Pediatr. 2011 Oct 29. [Epub ahead of print].

Oct 2011

Eubelen C, Brendel F, Belche JL, Freyens A, Vanbelle S, Giet D. Effect of an audiovisual message for tetanus booster vaccination broadcast in the waiting room. BMC Fam Pract. 2011 Sep 28; 12(1):104. [Epub ahead of print].
Hendrikx LH, Schure RM, Oztürk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine. 2011 Sep 16; 29(40):6874-80.
Quinn HE, McIntyre PB. The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia. Bull World Health Organ. 2011 Sep 1; 89(9):666-74.
Weston W, Messier M, Friedland LR, Wu X, Howe B. Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine. Vaccine. 2011 Sep 23. [Epub ahead of print].

Sep 2011

Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS. Immunization of Teenagers with a Fifth Dose of Reduced DTaP-IPV Induces High Levels of Pertussis Antibodies with a Significant Increase in Opsonophagocytic Activity. Clin Vaccine Immunol. 2011 Aug; 18(8):1269-74.
Cooper Robbins SC, Leask J, Hayles EH, Sinn JK. Midwife attitudes: An important determinant of maternal postpartum pertussis booster vaccination. Vaccine. 2011 Aug 5; 29(34):5591-4.
Greer AL, Fisman DN. Use of Models to Identify Cost-effective Interventions: Pertussis Vaccination for Pediatric Health Care Workers. Pediatrics. 2011 Aug 15. [Epub ahead of print].
Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Vaccine. 2011 Aug 5; 29(34):5725-30.
Toska A, Saridi M, Rekleiti M, Wozniak G, Souliotis K, Apostolopoulou E. Tetanus vaccination coverage among nurses in Greece. Am J Infect Control. 2011 Aug; 39(6):532-3.

Aug 2011

Validation of neonatal tetanus elimination in Burundi and the Comoros by a lot quality assurance cluster sampling survey, 1 October 2008- 30 September 2009. Wkly Epidemiol Rec. 2011 Jul 8; 86(28):289-99.
Friedrich MJ. Research aims to boost pertussis control. JAMA. 2011 Jul 6; 306(1):27-9.
Hanson MP, Kwan-Gett TS, Baer A, Rietberg K, Ohrt M, Duchin JS. Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (tdap) vaccination: King County, Washington, 2002 through 2007. Arch Pediatr Adolesc Med. 2011 Jul; 165(7):647-52.
Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011 Jul; 11(7):557-70.

Jul 2011

Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS. Immunization with a fifth dose of reduced dTap-IPV to teenagers induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity. Clin Vaccine Immunol. 2011 Jun 15. [Epub ahead of print].
Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, Alvarez J, Minguel S, Camps N, Caylà J, Batalla J, Codina G, Domínguez A. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine. 2011 Jun 6; 29(25):4244-8.
Hendrikx LH, de Rond LG, Oztürk K, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Vaccine. 2011 Jun 12. [Epub ahead of print].
Nelson CB, de Quadros C. Coalition against typhoid: A new, global initiative to advance typhoid vaccination. Vaccine. 2011 Jun 20. [Epub ahead of print].
Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA. Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization. Clin Vaccine Immunol. 2011 Jun; 18(6):954-62.

Jun 2011

Atanasovski M, Dele-Michael A, Dasgeb B, Ganger L, Mehregan D. A case report of Gianotti-Crosti post vaccination with MMR and dTaP. Int J Dermatol. 2011 May; 50(5):609-10.
Canning D, Razzaque A, Driessen J, Walker DG, Streatfield PK, Yunus M. The effect of maternal tetanus immunization on children's schooling attainment in Matlab, Bangladesh: Follow-up of a randomized trial. Soc Sci Med. 2011 May; 72(9):1429-36.
Robbins SC, Leask J, Hayles EH, Sinn JK. Midwife attitudes: An important determinant of maternal postpartum pertussis booster vaccination completion. Vaccine. 2011 May 27. [Epub ahead of print].
Toska A, Saridi M, Rekleiti M, Wozniak G, Souliotis K, Apostolopoulou E. Tetanus vaccination coverage among nurses in Greece. Am J Infect Control. 2011 May 24. [Epub ahead of print].
Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011 May 18. [Epub ahead of print].

May 2011

Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine. 2011 Apr 18; 29(18):3438-42.
Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, Alvarez J, Minguel S, Camps N, Caylà J, Domínguez A. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine. 2011 Apr 11. [Epub ahead of print].
Durand C, Flament E. Pertussis vaccination for parents: Proposal and evaluation of two professional practices in a maternity hospital. Arch Pediatr. 2011 Apr; 18(4):362-369.
Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011 Apr; 204(4):334.e1-5.
Halperin BA, Halperin SA. The reemergence of pertussis and infant deaths: is it time to immunize pregnant women? Future Microbiol. 2011 Apr; 6:367-9.
Mortimer PP. The diphtheria vaccine debacle of 1940 that ushered in comprehensive childhood immunization in the United Kingdom. Epidemiol Infect. 2011 Apr; 139(4):487-93.
Scott LJ. Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults. Paediatr Drugs. 2011 Apr 1; 13(2):133-5.
Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Clin Vaccine Immunol. 2011 Apr 20. [Epub ahead of print].

Apr 2011

Aboal Beato MA, Martínez Suárez M, Castrillón Piñeiro LM, Juncal Fondevila AR. Protective tetanus antibody titres and new re-vaccination requirements. Aten Primaria. 2011 Mar 10. [Epub ahead of print].
Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr. 2011 Mar; 65(3):329-34.
Hofmann C, Baur MO, Schroten H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol. 2011 Mar; 258(3):500-1.
Izadi M, Afsharpaiman S, Jonaidi Jafari N, Ranjbar R, Gooya MM, Robat Sarpooshi J, Esfahani AA, Soheylipoor H. Immunization status of Iranian military recruits against Bordetella pertussis infection (whooping cough). J Infect Dev Ctries. 2011 Mar 21; 5(3):224-6.
Trollfors B, Dotevall L, Sundh V, Welinder-Olsson C. Pertussis after end of a mass vaccination project-End of the "vaccination honey-moon". Vaccine. 2011 Mar 16; 29(13):2444-50.

Mar 2011

Durand C, Flament E. Pertussis vaccination for parents: Proposal and evaluation of two professional practices in a maternity hospital. Arch Pediatr. 2011 Feb 24. [Epub ahead of print].
Hendrikx LH, Oztürk K, de Rond LG, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins Vaccine. 2011 Feb 4; 29(7):1431-7.
Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q, De Zeng T, Liu TX, Li XB, Huang YN, Deng ML, Zhang YP, Ortiz E. Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China Vaccine. 2011 Feb 24; 29(10):1913-20.
Trollfors B, Dotevall L, Sundh V, Welinder-Olsson C. Pertussis after end of a mass vaccination project-End of the "vaccination honey-moon" Vaccine. 2011 Feb 1. [Epub ahead of print].

Feb 2011

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011 Jan 14; 60(1):13-5.
Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011 Jan 26. [Epub ahead of print].
Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr. 2011 Jan 12. [Epub ahead of print].
Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q, De Zeng T, Liu TX, Li XB, Huang YN, Deng ML, Zhang YP, Ortiz E. Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China. Vaccine. 2011 Jan 8. [Epub ahead of print].
Mortimer PP. The diphtheria vaccine debacle of 1940 that ushered in comprehensive childhood immunization in the United Kingdom. Epidemiol Infect. 2011 Jan 13:1-7. [Epub ahead of print].
Ulloa-Gutierrez R, Boza R, Carvajal-Riggioni D, Baltodano A. Pertussis: should we improve intensive care management or vaccination strategies? Expert Rev Vaccines. 2011 Jan; 10(1):49-53.

Jan 2011

Hendrikx LH, Oztürk K, de Rond LG, Veenhoven RH, Sanders EA, Berbers GA, Buisman AM. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins. Vaccine. 2010 Dec 24. [Epub ahead of print].
Kuehn BM. Panel backs wider pertussis vaccination to curb outbreaks, prevent deaths. JAMA. 2010 Dec 22; 304(24):2684-6.
Scott LJ. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults. BioDrugs. 2010 Dec 1; 24(6):387-406.

Dec 2010

Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci. 2010 Nov 7; 277(1698):3239-45.
Okada K, Komiya T, Yamamoto A, Takahashi M, Kamachi K, Nakano T, Nagai T, Okabe N, Kamiya H, Nakayama T. Safe and effective booster immunization using DTaP in teenagers. Vaccine. 2010 Nov 10; 28(48):7626-33.
Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine. 2010 Nov 23; 28(50):8001-7.
Zhang L, Xu Y, Zhao J, Kallonen T, Cui S, Xu Y, Hou Q, Li F, Wang J, He Q, Zhang S. Effect of vaccination on Bordetella pertussis strains, China. Emerg Infect Dis. 2010 Nov; 16(11):1695-701.

Nov 2010

Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010 Oct 1; 85(40):385-400.
Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008. MMWR Morb Mortal Wkly Rep. 2010 Oct 15; 59(40):1302-6.
de Vries R, Kretzschmar M, Schellekens JF, Versteegh FG, Westra TA, Roord JJ, Postma MJ. Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. PLoS One. 2010 Oct 15; 5(10):e13392.
Larnaudie S, Guiso N, Baptiste C, Desaint C, Deforges L, Lebon P, Soubeyrand B, Launay O. Humoral immunity of dTap-IPV vaccine (REPEVAX(®)) administered one month after dT-IPV vaccine (REVAXIS(®)) in adults with unknown vaccination history. Hum Vaccin. 2010 Oct 1; 6(10). [Epub ahead of print].
Rittle C. Pertussis-the case for universal vaccination. J Spec Pediatr Nurs. 2010 Oct; 15(4):282-91.

Oct 2010

Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol. 2010Sep; 59(Pt 9):1029-36.
Hofmann C, Baur MO, Schroten H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol. 2010 Sep 30. [Epub ahead of print].
Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health. 2010Sep; 100(9):1635-40. Epub 2010 Jul 15.
Okada K, Komiya T, Yamamoto A, Takahashi M, Kamachi K, Nakano T, Nagai T, Okabe N, Kamiya H, Nakayama T. Safe and effective booster immunization using DTaP in teenagers. Vaccine. 2010 Sep 27. [Epub ahead of print].
Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine. 2010 Sep 24. [Epub ahead of print].
von Linstow ML, Pontoppidan PL, von König CH, Cherry JD, Hogh B. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. Eur J Pediatr. 2010 Sep;169(9):1119-22. Epub 2010 Apr 8.

Sep 2010

Cheng PJ, Huang SY, Shaw SW, Kao CC, Chueh HY, Chang SD, Hsu TY, Kung FT, Hsieh TT. Factors influencing women's decisions regarding pertussis vaccine: A decision-making study in the Postpartum Pertussis Immunization Program of a teaching hospital in Taiwan. Vaccine. 2010 Aug 2; 28(34):5641-7.
Gautret P, Yong W, Soula G, Parola P, Brouqui P, DelVecchio Good MJ. Determinants of tetanus, diphtheria and poliomyelitis vaccinations among Hajj pilgrims, Marseille, France. Eur J Public Health. 2010 Aug;20(4):438-42.
Jain N, Stokley S, Cohn A. Receipt of tetanus-containing vaccinations among adolescents aged 13 to 17 years in the United States: National Immunization Survey-Teen 2007. Clin Ther. 2010 Aug; 32(8):1468-78.
Westra TA, de Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther. 2010 Aug; 32(8):1479-95.

Aug 2010

Validation of neonatal tetanus elimination in Gujarat and Himachal Pradesh, India, 2008. Wkly Epidemiol Rec. 2010 Jul 2; 85(27):265-71. English, French.
Kharbanda EO Md Mph, Stockwell MS Md Mph, Colgrove J Phd, Natarajan K Ma, Rickert VI Psyd. Changes in Tdap and MCV4 Vaccine Coverage Following Enactment of a Statewide Requirement of Tdap Vaccination for Entry Into Sixth Grade. Am J Public Health. 2010 Jul 15. [Epub ahead of print].
Trick WE, Linn ES, Jones Z, Caquelin C, Kee R, Morita JY. Using computer decision support to increase maternal postpartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol. 2010 Jul; 116(1):51-7.

Jul 2010

Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci. 2010 Jun [Epub ahead of print].
Cheng PJ, Huang SY, Shaw SW, Kao CC, Chueh HY, Chang SD, Hsu TY, Kung FT, Hsieh TT. Factors influencing women's decisions regarding pertussis vaccine: A decision-making study in the Postpartum Pertussis Immunization Program of a teaching hospital in Taiwan. Vaccine. 2010 Jun 1[Epub ahead of print].
Fontanilla JM, Kirkland KB, Cotter JG, Talbot EA. Ability of healthcare workers to recall previous receipt of tetanus-containing vaccination. Infect Control Hosp Epidemiol. 2010 Jun; 31(6):647-9.
Li G, Zhang H, Zhou W, Ye Q, Li F, Wang H, Hou Q, Xu Y, Ma X, Tan Y, Wang L, Li Y, Li H, Meng F, Liang Q, Liu A, Qin C, Wei W, Liu J, Ruan C, Tao W, Zhang S, Zheng H, Zhu F. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization. Vaccine. 2010 Jun 7; 28(25):4215-2Epub 2010 Apr 15.
Nates SV, Frias M, Belfiore S, Isa MB, Martinez LC, Chuit R, Armoni J, Luxemburger C. Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city. Epidemiol Infect. 2010 Jun 29:1-1[Epub ahead of print].
Posfay-Barbe KM, Kobela M, Sottas C, Grillet S, Taguebue J, Ekoe T, Lambert PH, Lecoultre C, Siegrist CA. Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory? Vaccine. 2010 Jun 17;28(27):4356-6 Epub 2010 May 4.

Jun 2010

Cherry JD, Heininger U, Richards DM, Storsaeter J, Gustafsson L, Ljungman M, Hallander HO. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol. 2010 May; 17(5):741-7.
Dalby T, Pedersen JW, Harboe ZB, Krogfelt KA. Antibody responses to pertussis toxin display different kinetics after clinical B. pertussis infection compared to after vaccination with an acellular pertussis vaccine. J Med Microbiol. 2010 May 27. [Epub ahead of print].
Posfay-Barbe KM, Kobela M, Sottas C, Grillet S, Taguebue J, Ekoe T, Lambert PH, Lecoultre C, Siegrist CA. Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: Waning of infancy-induced immune memory? Vaccine. 2010 May 4. [Epub ahead of print].
Stevner MA. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish Children-a comment. Eur J Pediatr. 2010 May 18. [Epub ahead of print].

May 2010

Blencowe, H.; Lawn, J.; Vandelaer, J.; Roper, M.; Cousens, S. Tetanus Toxoid Immunization to Reduce Mortality From Neonatal Tetanus. Int J Epidemiol; 39 (Suppl 1): i102-i109; April, 2010.
Chandir, S.; Khan, A. J.; Hussain, H.; Usman, H. R.; Khowaja, S.; Halsey, N. A.; Omer, S. B. Effect of Food Coupon Incentives on Timely Completion of DTP Immunization Series in Children From a Low-Income Area in Karachi, Pakistan: a Longitudinal Intervention Study. Vaccine; 28 (19): 3473-3478; April 26, 2010.
Guthmann, J. P.; Fonteneau, L.; Antona, D.; Levy-Bruhl, D. Factors Associated With Tetanus Vaccination Coverage in Adults in France and With Knowledge of Vaccination Status. Med Mal Infect; April 16, 2010. [Epub ahead of print].
Li, G.; Zhang, H.; Zhou, W.; Ye, Q.; Li, F.; Wang, H.; Hou, Q.; Xu, Y.; Ma, X.; Tan, Y.; Wang, L.; Li, Y.; Li, H.; Meng, F.; Liang, Q.; Liu, A.; Qin, C.; Wei, W.; Liu, J.; Ruan, C.; Tao, W.; Zhang, S.; Zheng, H.; Zhu, F. Safety and Immunogenicity of a Diphtheria, Tetanus, Acellular Pertussis and Haemophilus Influenzae Type b Combination Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in Chinese Infants and Toddlers for Primary and Booster Immunization. Vaccine; April 15, 2010. [Epub ahead of print].
Monteiro, S. A.; Takano, O. A.; Waldman, E. A. Surveillance for Adverse Events After DTaP/Hib Vaccination in Brazil: Sensitivity and Factors Associated With Reporting. Vaccine; 28 (18): 3127-3133; April, 2010.
Pereira, A.; Pietro Pereira, A. S.; Silva, C. L.; de Melo, Rocha G.; Lebrun, I.; Sant'Anna, O. A.; Tambourgi, D. V. Antibody Response From Whole-Cell Pertussis Vaccine Immunized Brazilian Children Against Different Strains of Bordetella Pertussis. Am J Trop Med Hyg; 82 (4): 678-682; April, 2010.
Tan, T. Q.; Gerbie, M. V. Pertussis and Patient Safety: Implementing Tdap Vaccine Recommendations in Hospitals. Jt Comm J Qual Patient Saf; 36 (4): 173-178; April, 2010.
von Linstow, M. L.; Pontoppidan, P. L.; von Konig, C. H.; Cherry, J. D.; Hogh, B. Evidence of Bordetella Pertussis Infection in Vaccinated 1-Year-Old Danish Children. Eur J Pediatr; April 8, 2010. [Epub ahead of print].

Apr 2010

Chandir, S.; Khan, A. J.; Hussain, H.; Usman, H. R.; Khowaja, S.; Halsey, N. A.; Omer, S. B. Effect of Food Coupon Incentives on Timely Completion of DTP Immunization Series in Children From a Low-Income Area in Karachi, Pakistan: A Longitudinal Intervention Study. Vaccine; March 1, 2010. [Epub ahead of print].
Cherry, J. D.; Heininger, U.; Richards, D. M.; Storsaeter, J.; Gustafsson, L.; Ljungman, M.; Hallander, H. O. Antibody Response Patterns to Bordetella Pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children With Pertussis. Clin Vaccine Immunol; March 24, 2010. [Epub ahead of print].
Girard, D. Z. The Distribution Over Time of Costs and Social Net Benefits for Pertussis Immunization Programs.Int J Health Care Finance Econ; 10 (1): 1-27; March, 2010.
Monteiro, S. A.; Takano, O. A.; Waldman, E. A. Surveillance for Adverse Events After DTaP/Hib Vaccination in Brazil: Sensitivity and Factors Associated With Reporting. Vaccine; 28 (18): 3127-3133; April, 2010.
Puissant-Lubrano, B.; Rostaing, L.; Kamar, N.; Abbal, M.; Fort, M.; Blancher, A. Impact of Rituximab Therapy on Response to Tetanus Toxoid Vaccination in Kidney-Transplant Patients. Exp Clin Transplant; 8 (1): 19-28; March, 2010.
Top, K. A.; Halperin, B. A.; Baxendale, D.; Kinnon-Cameron, D.; Halperin, S. A. Pertussis Immunization in Paediatric Healthcare Workers: Knowledge, Attitudes, Beliefs, and Behaviour. Vaccine; 28 (10): 2169-2173; March 2, 2010.
White, O. J.; Rowe, J.; Richmond, P.; Marshall, H.; McIntyre, P.; Wood, N.; Holt, P. G. Th2-Polarisation of Cellular Immune Memory to Neonatal Pertussis Vaccination. Vaccine; 28 (14): 2648-2652; March, 2010.
Zhu, F.; Zhang, S.; Hou, Q.; Zhang, Y.; Xu, Y.; Ma, X.; Lu, X.; Pan, H.; Chen, D.; Ramakrishnan, G.; Zhao, R.; Tang, H.; Van Der, Meeren O.; Bock, H. L. Booster Vaccination Against Pertussis in Chinese Children at Six Years of Age Using Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix). Hum Vaccin; 6 (3); March 3, 2010. [Epub ahead of print].

Mar 2010

Chandir, S.; Khan, A. J.; Hussain, H.; Usman, H. R.; Khowaja, S.; Halsey, N. A.; Omer, S. B. Effect of Food Coupon Incentives on Timely Completion of DTP Immunization Series in Children From a Low-Income Area in Karachi, Pakistan: A Longitudinal Intervention Study. Vaccine;February 28, 2010. [Epub ahead of print].
Duranoglu, L.; Sonmez, C.; Vurucu, S.; Kurtoglu, D.; Kesik, V.; Coplu, N.; Koseoglu, V.; Esen, B.; Ozcan, O. Evaluation of Pertussis Immunity Status in Schoolchildren Immunized With Whole-Cell Vaccine. Epidemiol Infect; 138 (2): 299-303; February, 2010.
Fernandes, J. R.; Wasserman, S.; Snider, D. P. Stimulation of Anti-Polio and Anti-HSV IgA Pre-Plasma Cell Response in Blood Following Parenteral Immunization With Tetanus-Diphtheria Vaccine. Vaccine; 28 (6): 1493-1498; February 10, 2010.
Livorsi, D. J.; Eaton, M.; Glass, J. Generalized Tetanus Despite Prior Vaccination and a Protective Level of Anti-Tetanus Antibodies. Am J Med Sci; 339 (2): 200-201; February, 2010.
Vermeulen, F.; Verscheure, V.; Damis, E.; Vermeylen, D.; Leloux, G.; Dirix, V.; Locht, C.; Mascart, F. Cellular Immune Responses of Preterm Infants After Vaccination With Whole-Cell or Acellular Pertussis Vaccines. Clin Vaccine Immunol; 17 (2): 258-262; February, 2010.

Feb 2010

Kim, S.; Oh, H.; Ham, O.; Chung, M. H.; Seo, W. Susceptibility and Factors of Pertussis Vaccination Adherence in Korean Health Care Workers. Am J Health Behav; 34 (1): 45-53; January, 2010.
Mandich, P.; Grandis, M.; Varese, A.; Geroldi, A.; Acquaviva, M.; Ciotti, P.; Gulli, R.; Doria-Lamba, L.; Fabrizi, G. M.; Giribaldi, G.; Pizzuti, A.; Schenone, A.; Bellone, E. Severe Neuropathy After Diphtheria-Tetanus-Pertussis Vaccination in a Child Carrying a Novel Frame-Shift Mutation in the Small Heat-Shock Protein 27 Gene. J Child Neurol; 25 (1): 107-109; January, 2010.
Top, K. A.; Halperin, B. A.; Baxendale, D.; kinnon-Cameron, D.; Halperin, S. A. Pertussis Immunization in Paediatric Healthcare Workers: Knowledge, Attitudes, Beliefs, and Behaviour. Vaccine; January 5, 2010. [Epub ahead of print].
White, O. J.; Rowe, J.; Richmond, P.; Marshall, H.; McIntyre, P.; Wood, N.; Holt, P. G. Th2-Polarisation of Cellular Immune Memory to Neonatal Pertussis Vaccination. Vaccine; January, 2010. [Epub ahead of print].

Jan 2010

Fernandes, J. R.; Wasserman, S.; Snider, D. P. Stimulation of Anti-Polio and Anti-HSV IgA Pre-Plasma Cell Response in Blood Following Parenteral Immunization With Tetanus-Diphtheria Vaccine. Vaccine; December 8, 2009. [Epub ahead of print].
Gautret, P.; Yong, W.; Soula, G.; Parola, P.; Brouqui, P.; vecchio Good, M. J. Determinants of Tetanus, Diphtheria and Poliomyelitis Vaccinations Among Hajj Pilgrims, Marseille, France. Eur J Public Health; December 3, 2009. [Epub ahead of print].
Livorsi, D. J.; Eaton, M.; Glass, J. Generalized Tetanus Despite Prior Vaccination and a Protective Level of Anti-Tetanus Antibodies. Am J Med Sci; December 16, 2009. [Epub ahead of print].
Rahman, M. Tetanus Toxoid Vaccination Coverage and Differential Between Urban and Rural Areas of Bangladesh. East Afr J Public Health; 6 (1): 26-31; April, 2009.
Vermeulen, F.; Verscheure, V.; Damis, E.; Vermeylen, D.; Leloux, G.; Dirix, V.; Locht, C.; Mascart, F. Cellular Immune Responses of Preterm Infants After Vaccination With Whole Cell or Acellular Pertussis Vaccines. Clin Vaccine Immunol; December 16, 2009. [Epub ahead of print].

Dec 2009

Validation of Neonatal Tetanus Elimination in the Congo by a Lot Quality-Assurance Cluster Sample Survey. Wkly Epidemiol Rec; 84 (45): 470-476; November 9, 2009.
Hendrikx, L. H.; Berbers, G. A.; Veenhoven, R. H.; Sanders, E. A.; Buisman, A. M. IgG Responses After Booster Vaccination With Different Pertussis Vaccines in Dutch Children 4 Years of Age: Effect of Vaccine Antigen Content. Vaccine; 27 (47): 6530-6536; November 5, 2009.
Matos, D. C.; Silva, A. M.; Neves, P. C.; Martins, R. M.; Homma, A.; Marcovistz, R. Pattern of Functional Antibody Activity Against Haemophilus Influenzae Type B (Hib) in Infants Immunized With Diphtheria-Tetanus-Pertussis/Hib Brazilian Combination Vaccine. Braz J Med Biol Res; 42 (12): 1242-1247; December, 2009.
Usman, H. R.; Kristensen, S.; Rahbar, M. H.; Vermund, S. H.; Habib, F.; Chamot, E. Determinants of Third Dose of Diphtheria-Tetanus-Pertussis (DTP) Completion Among Children Who Received DTP1 at Rural Immunization Centres in Pakistan: a Cohort Study. Trop Med Int Health; November 17, 2009. [Epub ahead of print].

Nov 2009

Dirix, V.; Verscheure, V.; Goetghebuer, T.; Hainaut, M.; Debrie, A. S.; Locht, C.; Mascart, FCytokine and Antibody Profiles in 1-Year-Old Children Vaccinated With Either Acellular or Whole-Cell Pertussis Vaccine During Infancy. Vaccine; 27 (43): 6042-6047; October 9, 2009.
Ownby, D. R.; Partridge, M. E.; Wegienka, G. R.; Woodcroft, K. J.; Peterson, E. L.; Joseph, C. L.; Williams, L. K.; Johnson, C. CInfluence of Dose and Frequency of Antigen Injection on IgE Development in Young Children: a Comparison of Fire Ant Stings and Tetanus Immunizations. Ann Allergy Asthma Immunol; 103 (4): 337-341; October, 2009.

Oct 2009

Hendrikx, L. H.; Berbers, G. A.; Veenhoven, R. H.; Sanders, E. A.; Buisman, A. M. IgG Responses After Booster Vaccination With Different Pertussis Vaccines in Dutch Children 4 Years of Age: Effect of Vaccine Antigen Content. Vaccine; September 1, 2009. [Epub ahead of print].
Postma, M. J.; de, Vries R.; Roord, J. Conclusions on (Cost-)Effectiveness of Pertussis Booster Vaccination Strategies Highly Dependent on Selections Made in Evidence Review. Vaccine; September 8, 2009. [Epub ahead of print].

Sep 2009

Clajus, C.; Spiegel, J.; Brocker, V.; Chatzikyrkou, C.; Kielstein, J. T. Minimal Change Nephrotic Syndrome in an 82 Year Old Patient Following a Tetanus-Diphteria-Poliomyelitis-Vaccination. BMC Nephrol; 10: 21; August 5, 2009.
Dirix, V.; Verscheure, V.; Goetghebuer, T.; Hainaut, M.; Debrie, A. S.; Locht, C.; Mascart, F. Cytokine and Antibody Profiles in 1-Year-Old Children Vaccinated With Either Acellular or Whole-Cell Pertussis Vaccine During Infancy. Vaccine; August 7, 2009. [Epub ahead of print].
Hallander, H. O.; Ljungman, M.; Jahnmatz, M.; Storsaeter, J.; Nilsson, L.; Gustafsson, L. Should Fimbriae Be Included in Pertussis Vaccines? Studies on ELISA IgG Anti-Fim2/3 Antibodies After Vaccination and Infection. APMIS; 117 (9): 660-671; September, 2009.
Hansted, E.; Andriuskeviciene, A.; Sakalauskas, R.; Kevalas, R.; Sitkauskiene, B. T-Cell-Based Diagnosis of Tuberculosis Infection in Children in Lithuania: a Country of High Incidence Despite a High Coverage With Bacille Calmette-Guerin Vaccination. BMC Pulm Med; 9: 41; August 18, 2009.
Healy, C. M.; Rench, M. A.; Castagnini, L. A.; Baker, C. J. Pertussis Immunization in a High-Risk Postpartum Population. Vaccine; 27 (41): 5599-5602; September 18, 2009.
Kim, S.; Oh, H.; Ham, O.; Chung, M. H.; Seo, W. Susceptibility and Factors of Pertussis Vaccination Adherence in Korean Health Care Workers. Am J Health Behav; 34 (1): 45-53; January, 2010.
Plosker, G. L. Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix): a Review of Its Use As a Single-Dose Booster Immunization in Individuals Aged 10-64 Years in the US. BioDrugs; 23 (4): 253-267; 2009.
Schneider, F.; Stanitz, E.; Kalacska, J.; Tompity, T.; Gabor, B. Whooping Cough in an Urban High School in Hungary. Conclusions of a Local Pertussis Outbreak. Orv Hetil; 150 (33): 1557-1561; August 16, 2009.
Zarei, S.; Jeddi-Tehrani, M.; Akhondi, M. M.; Zeraati, H.; Pourheidari, F.; Ostadkarampour, M.; Tavangar, B.; Shokri, F. Primary Immunization With a Triple Diphtheria-Tetanus-Whole Cell Pertussis Vaccine in Iranian Infants: an Analysis of Antibody Response. Iran J Allergy Asthma Immunol; 8 (2): 85-93; June, 2009.

Aug 2009

ACOG Committee Opinion No. 438: Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Obstet Gynecol; 114 (2 Pt 1): 398-400; August, 2009.
Birkebaek, N. H. Bordetella Pertussis Booster Vaccination for Health Care Personnel Immediately Following a Pertussis Outbreak in a Hospital? Clin Infect Dis; 49 (4): 588-590; August 15, 2009.
Coudeville, L.; Van, Rie A.; Getsios, D.; Caro, J. J.; Crepey, P.; Nguyen, V. H. Adult Vaccination Strategies for the Control of Pertussis in the United States: an Economic Evaluation Including the Dynamic Population Effects. PLoS One; 4 (7): e6284; July 16, 2009.
Dommergues, M. A.; Robichon, F.; Soltane, S.; Refol, S.; Panel, P.; Foucaud, P. Vaccination of Newborns With High Risk of Tuberculosis in a French Maternity Hospital. Arch Pediatr; 16 (9): 1270-1275; July 24, 2009.
Duranoglu, L.; Sonmez, C.; Vurucu, S.; Kurtoglu, D.; Kesik, V.; Coplu, N.; Koseoglu, V.; Esen, B.; Ozcan, O. Evaluation of Pertussis Immunity Status in Schoolchildren Immunized With Whole-Cell Vaccine. Epidemiol Infect: 1-5; July 7, 2009. [Epub ahead of print].
Mitka, M. Unvaccinated Children Face Pertussis Risk: Some Parents Fear Vaccine More Than Infection. JAMA; 302 (3): 242, 244; July 15, 2009.
Walter, E. B.; Allred, N.; Rowe-West, B.; Chmielewski, K.; Kretsinger, K.; Dolor, R. J. Cocooning Infants: Tdap Immunization for New Parents in the Pediatric Office. Acad Pediatr; July 11, 2009. [Epub ahead of print].

Jul 2009

Al Aswad, I; Shubair, M. E. Efficacy of Diphtheria and Tetanus Vaccination in Gaza, Palestine. East Mediterr Health J; 15 (2): 285-294; March, 2009.
Glanz, J. M.; McClure, D. L.; Magid, D. J.; Daley, M. F.; France, E. K.; Salmon, D. A.; Hambidge, S. J. Parental Refusal of Pertussis Vaccination Is Associated With an Increased Risk of Pertussis Infection in Children. Pediatrics; 123 (6): 1446-1451; June, 2009.
Shah, S. S.; Davis, M. M. Old Disease, Innovative Response: Accelerating Infant Vaccination During a Community Pertussis Outbreak. JAMA; 301 (21): 2260-2261; June 3, 2009.
Waters, V.; Jamieson, F.; Richardson, S. E.; Finkelstein, M.; Wormsbecker, A.; Halperin, S. A. Outbreak of Atypical Pertussis Detected by Polymerase Chain Reaction in Immunized Preschool-Aged Children. Pediatr Infect Dis J; 28 (7): 582-587; July, 2009.

Jun 2009

Batalla Martinez, C. Response by the Author: Commercial Criteria or Epidemiological Criteria in Anti-Tetanus Vaccination? Aten Primaria; 41 (5): 293-294; May, 2009.
Bronson-Lowe, D.; Anderson, S. M. Effects of a Minimum Interval Immunization Schedule for Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccination During a Pertussis Outbreak. Arch Pediatr Adolesc Med; 163 (5): 417-421; May, 2009.
Palomo, L.; Gervas, J. Commercial Criteria or Epidemiological Criteria in Anti-Tetanus Vaccination? Aten Primaria; 41 (5): 292-293; May, 2009.

May 2009

FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine. MMWR Morb Mortal Wkly Rep; 58 (14): 374-375; April 17, 2009.
Abarca, V. K.; Cerda, L. J.; Ferreccio, R. C. Adverse Reactions to Diphtheria-Pertussis-Tetanus Vaccine in the Chilean Immunization Program. Rev Med Chil; 137 (1): 10-17; January, 2009.
de Greeff, S. C.; Lugner, A. K.; van den Heuvel, D. M.; Mooi, F. R.; de Melker, H. E. Economic Analysis of Pertussis Illness in the Dutch Population: Implications for Current and Future Vaccination Strategies. Vaccine; 27 (13): 1932-1937; March 18, 2009.
Toikka, P.; Helminen, M.; Rajalahti, I.; Valve, K.; Korppi, M. Infantile Tuberculosis--to Be Considered Again. Duodecim; 125 (1): 73-77; 2009.

Apr 2009

Girard, D. Z. The Distribution Over Time of Costs and Social Net Benefits for Pertussis Immunization Programs. Int J Health Care Finance Econ; March 18, 2009. [Epub ahead of print.]
Higginbotham, T. W.; Cleveland, K. W. Decreasing Childhood Pertussis Infection Through Vaccination of the Elderly. Consult Pharm; 23 (12): 976, 979-976, 981; December, 2008.
Lasserre, A.; Riviere, M.; Blanchon, T.; Alvarez, F.; Gaillat, J.; Romain, O.; Bouhour, D.; Guiso, N. Awareness and Adherence to Pertussis Vaccination Guidelines by Occupational Medicine Physicians in Paris Healthcare Institution. Med Mal Infect; March 12, 2009. [Epub ahead of print.]
Mu, J.; Jeyanathan, M.; Small, C. L.; Zhang, X.; Roediger, E.; Feng, X.; Chong, D.; Gauldie, J.; Xing, Z. Immunization With a Bivalent Adenovirus-Vectored Tuberculosis Vaccine Provides Markedly Improved Protection Over Its Monovalent Counterpart Against Pulmonary Tuberculosis. Mol Ther; March 24, 2009. [Epub ahead of print.]
Spycher, B. D.; Silverman, M.; Egger, M.; Zwahlen, M.; Kuehni, C. E. Routine Vaccination Against Pertussis and the Risk of Childhood Asthma: a Population-Based Cohort Study. Pediatrics; 123 (3): 944-950; March, 2009.

Mar 2009

Immunization of Adult Population of Russia Against Diphtheria in 2006-2007. Zh Mikrobiol Epidemiol Immunobiol;(6): 27-31; November, 2008.
Influence of Preliminary Vaccination With Tetanus Antitoxin on Hemodynamic Restoration in Patients After Hemorrhagic Shock at Thoracic Surgery. Patol Fiziol Eksp Ter; (4): 10-11; October, 2008.
Berbers, G. A.; de Greeff, S. C.; Mooi, F. R. Improving Pertussis Vaccination. Hum Vaccin; 5 (6); June 8, 2009.
Cardenosa, N.; Romero, M.; Quesada, M.; Oviedo, M.; Carmona, G.; Codina, G.; Jansa, J. M.; Dominguez, A. Is the Vaccination Coverage Established Enough to Control Pertussis, or It Is a Re-Emerging Disease? Vaccine; February 5, 2009. [Epub ahead of print].
Launay, O.; Toneatti, C.; Bernede, C.; Njamkepo, E.; Petitprez, K.; Leblond, A.; Larnaudie, S.; Goujon, C.; Ungeheuer, M. N.; Ajana, F.; Raccurt, C.; Beytout, J.; Chidiac, C.; Bouhour, D.; Guillemot, D.; Guiso, N. Antibodies to Tetanus, Diphtheria and Pertussis Among Healthy Adults Vaccinated According to the French Vaccination Recommendations. Hum Vaccin; 5 (5); May 9, 2009.
Masthi, N. R.; Bharat, G.; Aswini; Chitra; Arul, P. P. A Clinico Epidemiological Study of Tetanus Cases Admitted to Epidemic Disease Hospital, Bangalore. Indian J Public Health; 52 (4): 210-211; October, 2008.
Murhekar, M. V.; Bitragunta, S.; Hutin, Y.; Ckakravarty, A.; Sharma, H. J.; Gupte, M. D. Immunization Coverage and Immunity to Diphtheria and Tetanus Among Children in Hyderabad, India. J Infect; 58(3): 191-196; February 3, 2009.
Reed, D. B.; Westneat, S. C. Exposure Risks and Tetanus Immunization Status in Farmers Ages 50 and Over. South Med J; February 6, 2009. [Epub ahead of print].
Ulloa-Gutierrez, R. Pertussis Vaccination in Newborns. Expert Rev Vaccines; 8 (2): 153-157; February, 2009.

Feb 2009

Litt, D. J.; Neal, S. E.; Fry, N. K. Changes in Genetic Diversity of the UK Bordetella Pertussis Population Between 1920 and 2006 Reflect Vaccination Coverage and the Emergence of a Single Dominant Clonal Type. J Clin Microbiol; January 21, 2009. [Epub ahead of print].

Jan 2009

Batalla Martinez, C. Changes in the Tetanus Vaccination Guidelines? Aten Primaria; 40 (12): 595-596; December, 2008.
McIntyre, P. B.; Burgess, M. A.; Egan, A.; Schuerman, L.; Hoet, B. Booster Vaccination of Adults With Reduced-Antigen-Content Diphtheria, Tetanus and Pertussis Vaccine: Immunogenicity 5 Years Post-Vaccination. Vaccine; December 15, 2008. [Epub ahead of print].
Paulke-Korinek, M.; Rendi-Wagner, P.; Kundi, M.; Tomann, B.; Wiedermann, U.; Kollaritsch, H. Pretravel Consultation: Rapid Dipstick Test As a Decision Guidance for the Application of Tetanus Booster Vaccinations. J Travel Med; 15 (6): 437-441; November, 2008.
Rank, C.; Quinn, H. E.; McIntyre, P. B. Pertussis Vaccine Effectiveness After Mass Immunization of High School Students in Australia. Pediatr Infect Dis J; December 22, 2008. [Epub ahead of print].
Sahin, N.; Salli, A.; Enginar, A. U.; Ugurlu, H. Reactive Arthritis Following Tetanus Vaccination: a Case Report. Mod Rheumatol; December 13, 2008. [Epub ahead of print].
Ulloa-Gutierrez, R.; Avila-Aguero, M. L. Pertussis in Latin America: Current Situation and Future Vaccination Challenges. Expert Rev Vaccines; 7 (10): 1569-1580; December, 2008.
Wiedenmayer, K. A.; Weiss, S.; Chattopadhyay, C.; Mukherjee, A.; Kundu, R.; Aye, R.; Tediosi, F.; Hetzel, M. W.; Tanner, M. Simplifying Paediatric Immunization With a Fully Liquid DTP-HepB-Hib Combination Vaccine: Evidence From a Comparative Time-Motion Study in India. Vaccine; 27 (5): 655-659; December 3, 2008.
Zielinski, A.; Rosinska, M. Comparison of Adverse Effects Following Immunization With Vaccine Containing Whole-Cell Vs. Acellular Pertussis Components. Przegl Epidemiol; 62 (3): 589-596; 2008.

Dec 2008

Chun, J. K.; Kim, C. K.; Kim, H. S.; Jung, G. Y.; Lee, T. J.; Kim, K. H.; Kim, D. S. The Role of a Whole Blood Interferon-Gamma Assay for the Detection of Latent Tuberculosis Infection in Bacille Calmette-Guerin Vaccinated Children. Diagn Microbiol Infect Dis; 62 (4): 389-394; December, 2008.
Wicker, S.; Zielen, S.; Rose, M. A. Attitudes of Healthcare Workers Toward Pertussis Vaccination. Expert Rev Vaccines; 7 (9): 1325-1328; November, 2008.

Nov 2008

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use As a Booster Dose. MMWR Morb Mortal Wkly Rep; 57 (39): 1078-1079; October 3, 2008.
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, and Haemophilus B Conjugate Vaccine and Guidance for Use in Infants and Children. MMWR Morb Mortal Wkly Rep; 57 (39): 1079-1080; October 3, 2008.
Ahmad, S. M.; Haskell, M. J.; Raqib, R.; Stephensen, C. B. Men With Low Vitamin A Stores Respond Adequately to Primary Yellow Fever and Secondary Tetanus Toxoid Vaccination. J Nutr; 138 (11): 2276-2283; November, 2008.
Frohna, J. G. No Increase in Cardiorespiratory Events Seen After Diphtheria-Tetanus-Acellular Pertussis Immunization. J Pediatr; 153 (5): 726; November, 2008.
Kurtoglu, D.; Gozalan, A.; Coplu, N.; Miyamura, K.; Ishida, S.; Morita, M.; Akin, L.; Esen, B. Pertussis Seroprevalence and Vaccination Status in Three Selected Province of Turkey. Mikrobiyol Bul; 42 (3): 389-398; July, 2008.
Omer, S. B.; Enger, K. S.; Moulton, L. H.; Halsey, N. A.; Stokley, S.; Salmon, D. A. Geographic Clustering of Nonmedical Exemptions to School Immunization Requirements and Associations With Geographic Clustering of Pertussis. Am J Epidemiol; October 15, 2008. [Epub ahead of print].
Rieber, N.; Graf, A.; Belohradsky, B. H.; Hartl, D.; Urschel, S.; Riffelmann, M.; Wirsing von Konig, C. H.; Liese, J. Differences of Humoral and Cellular Immune Response to an Acellular Pertussis Booster in Adolescents With a Whole Cell or Acellular Primary Vaccination. Vaccine; October 10, 2008. [Epub ahead of print].

Oct 2008

Chitkara, A. J.; Kukreja, S.; Shah, R. C. Pertussis and Diphtheria Immunization. Indian Pediatr; 45 (9): 723-727; September, 2008.
Del Corro, M. R.; Vargas-Roman, M. I.; Garcia, R. I.; Prieto, R. G.; de Miguel, A. G. Tetanus Vaccination in Adult Population: Coverage, Registration and Compliance. Hum Vaccin; 5 (2); February 14, 2009.
Dylag, A. M.; Shah, S. I. Administration of Tetanus, Diphtheria, and Acellular Pertussis Vaccine to Parents of High-Risk Infants in the Neonatal Intensive Care Unit. Pediatrics; 122 (3): e550-e555; September, 2008.
Gabutti, G. The Value of Booster Vaccinations Against Diphtheria, Tetanus, Pertussis and Poliomyelitis. J Prev Med Hyg; 49 (1): 47-54; March, 2008.
Kashef, S.; Ghazizadeh, F.; Derakhshan, A.; Farjadian, S.; Alyasin, S. Antigen-Specific Antibody Response in Juvenile-Onset SLE Patients Following Routine Immunization With Tetanus Toxoid. Iran J Immunol; 5 (3): 181-184; September, 2008.
Savolainen, L.; Pusa, L.; Kim, H. J.; Sillanpaa, H.; Seppala, I.; Tuuminen, T. Pilot Study of Diagnostic Potential of the Mycobacterium Tuberculosis Recombinant HBHA Protein in a Vaccinated Population in Finland. PLoS ONE; 3 (9): e3272; September 25, 2008.

Sep 2008

Calderon, M.; Feja, K. N.; Ford, P.; Frenkel, L. D.; Gram, A.; Spector, D.; Tolan, R. W., Jr. Implementation of a Pertussis Immunization Program in a Teaching Hospital: an Argument for Federally Mandated Pertussis Vaccination of Health Care Workers. Am J Infect Control; 36 (6): 392-398; August, 2008.
Flatz-Jequier, A.; Posfay-Barbe, K. M.; Pfister, R. E.; Siegrist, C. A. Recurrence of Cardiorespiratory Events Following Repeat DTaP-Based Combined Immunization in Very Low Birth Weight Premature Infants. J Pediatr; 153 (3): 429-431; September, 2008.
Karatepe, M. The Role of Turkish Physicians in the Vaccination Against Typhus During the Years of World War I. Mikrobiyol Bul; 42 (2): 301-313; April, 2008.
Locht, C. A Common Vaccination Strategy to Solve Unsolved Problems of Tuberculosis and Pertussis? Microbes Infect; July 10, 2008. [Epub ahead of print].
Poland, G. A.; Jacobson, R. M.; Boyce, T. Health Care Worker Pertussis Immunization Requirements and Patient Safety. Am J Infect Control; 36 (6): 390-391; August, 2008.
Rakotovao, D. N.; Imbert, P.; Rakoto, F. A.; Ramorasata, J. A.; Razafimamonjy, N.; Rakotoarisoa, H.; Le Fleche-Mateos, A.; Carod, J. F. Fatal Diphtheria in a Child Wrongfully Contraindicated for Vaccination in Madagascar. Med Trop (Mars ); 68 (3): 306-307; June, 2008.
Schuh, A.; Schmickal, T. Tetanus Va ccination and Anti-Rabies-Inoculation. MMW Fortschr Med; 150 (26-27): 38, 40; June 26, 2008.
Siegrist, C. A. Blame Vaccine Interference, Not Neonatal Immunization, for Suboptimal Responses After Neonatal Diphtheria, Tetanus, and Acellular Pertussis Immunization. J Pediatr; 153 (3): 305-307; September, 2008.

Aug 2008

Use of Mass Tdap Vaccination to Control an Outbreak of Pertussis in a High School--Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep; 57 (29): 796-799; July 25, 2008.
Sandora, T. J.; Gidengil, C. A.; Lee, G. M. Pertussis Vaccination for Health Care Workers. Clin Microbiol Rev; 21 (3): 426-434; July, 2008.
Yalcin, S. S.; Gumus, A.; Yurdakok, K. Prophylactic Use of Acetaminophen in Children Vaccinated With Diphtheria-Tetanus-Pertussis. World J Pediatr; 4 (2): 127-129; May, 2008.

Jul 2008

Gidengil, C. A.; Sandora, T. J.; Lee, G. M. Tetanus-Diphtheria-Acellular Pertussis Vaccination of Adults in the USA. Expert Rev Vaccines; 7 (5): 621-634; July, 2008.
Jeon, K.; Ji, S. H.; Oh, S. Y.; Lee, J. B.; Kim, H. J.; Choi, C. M. Boosted Reaction on Two-Step Tuberculin Skin Test Among Military Personnel in South Korea, a Setting With an Intermediate Burden of Tuberculosis and Routine Bacille Calmette-Guerin Vaccination. J Korean Med Sci; 23 (3): 402-405; June, 2008.
Lee, G. M.; Riffelmann, M.; Wirsing von Konig, C. H. Cost-Effectiveness of Adult Pertussis Vaccination in Germany. Vaccine; 26 (29-30): 3673-3679; July 4, 2008.
Rioja, S.; Jund, J.; Gaillat, J. Are Pertussis Vaccination Guidelines Applied to Adults and Health Care Workers? Med Mal Infect; June 11, 2008. [Epub ahead of print].
van Riet, E.; Retra, K.; Adegnika, A. A.; Jol-van der Zijde CM; Uh, H. W.; Lell, B.; Issifou, S.; Kremsner, P. G.; Yazdanbakhsh, M.; van Tol, M. J.; Hartgers, F. C. Cellular and Humoral Responses to Tetanus Vaccination in Gabonese Children. Vaccine; 26 (29-30): 3690-3695; July 4, 2008.

Jun 2008

Biasutti, C.; Moraes-Pinto, M. I.; Segurado, A. C. Antibody Response After Vaccination With Tetanus and Diphtheria Toxoids in Human T-Cell Lymphotropic Virus Type 1 Asymptomatic Carriers. Vaccine; 26 (23): 2808-2810; June 2, 2008.
Carbone, T.; McEntire, B.; Kissin, D.; Kelly, D.; Steinschneider, A.; Violaris, K.; Karamchandani, N. Absence of an Increase in Cardiorespiratory Events After Diphtheria-Tetanus-Acellular Pertussis Immunization in Preterm Infants: a Randomized, Multicenter Study. Pediatrics; 121 (5): e1085-e1090; May, 2008.
Hviid, A. Acellular Pertussis Preschool Booster Vaccination. Pediatr Infect Dis J; 27(6): 573-574; May 2, 2008.
Lin, J. C.; Lin, T. Y.; Perng, W. C.; Mai, C. S.; Chen, Y. H.; Ku, C. H.; Chang, F. Y. An Outbreak of Tuberculosis in a Bacillus Calmette-Guerin-Vaccinated Military Population. Mil Med; 173 (4): 388-392; April, 2008.
Murphy, T. V.; Slade, B. A.; Broder, K. R.; Kretsinger, K.; Tiwari, T.; Joyce, P. M.; Iskander, J. K.; Brown, K.; Moran, J. S. Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 57 (RR-4): 1-51; May 30, 2008.
Pedersen, T. Pertussis--a Life-Threatening Infection in Infants. Is There a Need for Booster Vaccination? Ugeskr Laeger; 170 (17): 1474; April 21, 2008.
Saffar, M.; Khalilian, A.; Ajami, A.; Saffar, H.; Qaheri, A. Seroimmunity to Diphtheria and Tetanus Among Mother-Infant Pairs; the Role of Maternal Immunity on Infant Immune Response to Diphtheria-Tetanus Vaccination. Swiss Med Wkly; 138 (17-18): 256-260; May 3, 2008.

May 2008

Korber, A.; Graue, N.; Rietkotter, J.; Kreuzfelder, E.; Grabbe, S.; Dissemond, J. Insufficient Tetanus Vaccination Status in Patients With Chronic Leg Ulcers. Results of a Prospective Investigation in 100 Patients. Dermatology; 217 (1): 69-73; April 21, 2008.
Lin, T. Y.; Wang, Y. H.; Huang, Y. C.; Chiu, C. H.; Lin, P. Y.; Tang, H.; Hoet, B.; Bock, H. L. Booster Vaccination at 6-8 Years of Age With a Reduced Antigen Content DTpa-IPV Vaccine Is Immunogenic and Safe After Priming With Whole-Cell Pertussis Vaccine. Hum Vaccin; 4 (1): 50-53; January, 2008.
Munafo, E.; Pogelli, R.; Sambo, F. Dosage of Antitetanic Antitotoxoid Antibodies in the Context of Antitetanic Procedures: Case Study Including a Group of Italian Railways Workers With Obligatory Antitetanic Vaccination. G Ital Med Lav Ergon; 29 (3 Suppl): 760-761; July, 2007.
Tangredi, G.; di, Carlo D.; Marchetti, L.; Viviano, L.; Giudici, M. Tetanus Vaccination and Antibody Tritation: Compulsory Vaccination at Work and the Role of the Occupational Medicine in the Induction of Protective Effects in the Population in General. G Ital Med Lav Ergon; 29 (3 Suppl): 749-751; July, 2007.
Vermeer-de Bondt, P. E.; van der Maas, N. A. The Effect of Age and Dose Number on the Risk of Collapse (Hypotonic-Hyporesponsive Episode) After Pertussis Vaccination. Pediatr Infect Dis J; 27 (4): 355-357; April, 2008.

Apr 2008

Cortese, M. M.; Baughman, A. L.; Zhang, R.; Srivastava, P. U.; Wallace, G. S. Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004. Pediatrics; 121 (3): 484-492; March, 2008.
Francis, P. T. Maternal Vaccination Against Pertussis. Lancet Infect Dis; 8 (4): 214; April, 2008.
Grgic-Vitek, M.; Klavs, I.; Kraigher, A. Re-Emergence of Pertussis in Slovenia: Time to Change Immunization Policy. Vaccine; 26 (15): 1874-1878; March 28, 2008.
Jackson, L. A.; Starkovich, P.; Dunstan, M.; Yu, O.; Nelson, J.; Dunn, J.; Rees, T.; Zavitkovsky, A.; Maus, D.; Froeschle, J. E.; Decker, M. Prospective Assessment of the Effect of Needle Length and Injection Site on the Risk of Local Reactions to the Fifth Diphtheria-Tetanus-Acellular Pertussis Vaccination. Pediatrics; 121 (3): e646-e652; March, 2008.
Laguna, C.; Martinez, L.; Sanchez, J. L.; Alegre, V. Squamous Cell Carcinoma at Tetanus Vaccination Site. J Eur Acad Dermatol Venereol; 2008 Mar 7 [Epub ahead of print].
Mooi, F. R.; de Greeff, S. C. Maternal Vaccination Against Pertussis - Authors' Reply. Lancet Infect Dis; 8 (4): 214-215; April, 2008.
Nakajima, H.; Kariya, H.; Ohata, R.; Ogura, H. Investigation of Immunity Level Against Diphtheria and Reinforcement of Immunity by Booster Vaccination for Infection Control Staff in Okayama Prefecture. Jpn J Infect Dis; 61 (2): 104-106; March, 2008.

Mar 2008

Conyn-van Spaendonck, M. A. The Control of Pertussis After Half a Century of Vaccination. Ned Tijdschr Geneeskd; 152 (2): 66-68; January 12, 2008.
de Greeff, S. C.; Mooi, F. R.; Schellekens, J. F.; de Melker, H. E. Impact of Acellular Pertussis Preschool Booster Vaccination on Disease Burden of Pertussis in The Netherlands. Pediatr Infect Dis J; February 7, 2008. [Epub ahead of print].
Hasnain, S.; Sheikh, N. H. Causes of Low Tetanus Toxoid Vaccination Coverage in Pregnant Women in Lahore District, Pakistan. East Mediterr Health J; 13 (5): 1142-1152; September, 2007.
Reinert, P.; Dejos, V.; Clyti, N.; Abitbol, V. Immunogenicity and Reactogenicity of DTPa-IPV-HBV/Hib and DTPa-IPV/Hib Vaccines Coadministered With 7-Valent Pneumococcal Conjugate Vaccine As Primary Vaccination and Booster in Healthy Infants, According to the French Vaccination Calendar. Arch Pediatr; February 11, 2008. [Epub ahead of print].

Feb 2008

McDonald, K. L.; Huq, S. I.; Lix, L. M.; Becker, A. B.; Kozyrskyj, A. L. Delay in Diphtheria, Pertussis, Tetanus Vaccination Is Associated With a Reduced Risk of Childhood Asthma. J Allergy Clin Immunol; January 17, 2008. [Epub ahead of print].
Saffar, M. J.; Ajami, A.; Khalilian, A. R.; Qaheri, A.; Saffar, H. Pertussis Seroimmunity Among Mother-Infant Pairs and Infant Immune Response to Pertussis Vaccination. Indian Pediatr; 44 (12): 916-918; December 7, 2007.
van der Maas, N. A.; David, S.; Kemmeren, J. M.; Vermeer-de Bondt, P. E. Safety Surveillance in the National Vaccination Programme; Fewer Adverse Events With the DTP-IPV-Hib Vaccine After the Transition to an Acellular Pertussis Component in 2005. Ned Tijdschr Geneeskd; 151 (49): 2732-2737; December 8, 2007.

Jan 2008

Bernsen, R. M.; Nagelkerke, N. J.; Thijs, C.; van der Wouden, J. C. Reported Pertussis Infection and Risk of Atopy in 8- to 12-Yr-Old Vaccinated and Non-Vaccinated Children. Pediatr Allergy Immunol; December 11, 2007. [Epub ahead of print].
Freitas, F. R.; Sato, H. K.; Aranda, C. M.; Arantes, B. A.; Pacheco, M. A.; Waldman, E. A. Adverse Events Following Diphtheria, Pertussis and Tetanus Vaccinations and Factors Associated With Severity. Rev Saude Publica; 41 (6): 1032-1041; December, 2007.
Khan, N.; Shastri, J.; Aigal, U.; Doctor, B. Resurgence of Diphtheria in the Vaccination Era. Indian J Med Microbiol; 25 (4): 434; October, 2007.
Martins, R. M.; Camacho, L. A.; Lemos, M. C.; de Noronha, T. G.; de Carvalho, M. H.; Greffe, N.; da Silva, M. M.; Perisse, A. R.; Maia, M. L.; Homma, A. Incidence of Hypotonic-Hyporesponsive Episodes Associated to the Combined DTP/Hib Vaccine Used in Brazilian National Immunizations Program. J Pediatr (Rio J); 83 (6): 523-528; November, 2007.
Shorvon, S.; Berg, A. Pertussis Vaccination and Epilepsy-an Erratic History, New Research and the Mismatch Between Science and Social Policy. Epilepsia; December 13, 2007. [Epub ahead of print].
Tasanen, K.; Renko, M.; Kandelberg, P.; Herva, R.; Oikarinen, A. Childhood Lichen Planus After Simultaneous Measles-Mumps-Rubella and Diphtheria-Tetanus-Pertussis-Polio Vaccinations. Br J Dermatol; December 14, 2007. [Epub ahead of print].

Nov 2007

Barreto, L.; Guasparini, R.; Meekison, W.; Noya, F.; Young, L.; Mills, E. Humoral Immunity 5 Years After Booster Immunization With an Adolescent and Adult Formulation Combined Tetanus, Diphtheria, and 5-Component Acellular Pertussis Vaccine. Vaccine; October 2, 2007. [Epub ahead of print].
Ibanez-Jimenez, A.; Pairet-Jofre, G.; Prat-Gonzalez, I.; Sanchez-Doblado, M. J.; Tauler-Suner, M. Randomized Clinical Trial on the Effectiveness of a Postal Reminder to Increase Tetanus-Diphtheria Vaccination Coverage in the Young Adult Population. Enferm Clin; 17 (4): 171-176; July, 2007.
Reinert, P.; Dejos, V.; Clyti, N.; Abitbol, V. Immunogenicity and Reactogenicity of DTPa-IPV-HBV/Hib and DTPa-IPV/Hib Vaccines Co-Administered With 7-Valent Pneumococcal Conjugate Vaccine As Primary Vaccination and Booster in Healthy Children, According to the French Vaccine Calendar. Arch Pediatr; October 24, 2007. [Epub ahead of print].
Silfverdal, S. A.; Ehlin, A.; Montgomery, S. M. Protection Against Clinical Pertussis Induced by Whole-Cell Pertussis Vaccination Is Related to Primo-Immunisation Intervals. Vaccine; 25 (43): 7510-7515; October 23, 2007.
Yeh, S. H.; Lieberman, J. M. Update on Adolescent Immunization: Pertussis, Meningococcus, HPV, and the Future. Cleve Clin J Med; 74 (10): 714-727; October, 2007.

Oct 2007

Immunological Reactivity in Children With Central Nervous System Injuries Immunized With Adsorbed Diphtheria-Tetanus Anatoxin M and Measles Virus Vaccines. Fiziol Cheloveka; 33 (4): 54-57; July, 2007.
Karam, A. G.; Cherry, J. D. Hypotonic and Hyporesponsive Episodes After Diptheria-Tetanus-Acellular Pertussis Vaccination. Pediatr Infect Dis J; 26 (10): 966-967; October, 2007.
Ozkan, S.; Aksakal, F. N.; Tuzun, H.; Aycan, S.; Maral, I.; Cirak, M. Y.; Bumin, M. A. Bordetella Pertussis Seroprevalence Among Vaccinated School Children in Ankara, Turkey. Infection; 35(5): 387-379; September, 2007.
Theeten, H.; Rumke, H.; Hoppener, F. J.; Vilatimo, R.; Narejos, S.; Van, Damme P.; Hoet, B. Primary Vaccination of Adults With Reduced Antigen-Content Diphtheria-Tetanus-Acellular Pertussis or DTpa-Inactivated Poliovirus Vaccines Compared to Diphtheria-Tetanus-Toxoid Vaccines. Curr Med Res Opin; September 25, 2007. [Epub ahead of print].
Wang, H. Q.; Guo, X.; Chen, L. J.; Yang, J.; He, J. G.; Luo, M.; He, X.; Zhou, Y. Q.; Cao, L. S.; Lu, Y.; Yin, D. P.; Chen, Y. S.; Xia, W.; Liang, X. F. Study on the Immunity of Diphtheria in Children at County Level With Different 4-Vaccine Coverage Rates Based on the Results From "National Immunization Program Review" in 2004. Zhonghua Liu Xing Bing Xue Za Zhi; 28 (5): 433-436; May, 2007.

Sep 2007

Banus, S.; Bottema, R. W.; Siezen, C. L.; Vandebriel, R. J.; Reimerink, J.; Mommers, M.; Koppelman, G. H.; Hoebee, B.; Thijs, C.; Postma, D. S.; Kimman, T. G.; Stelma, F. F. A Toll-Like Receptor 4 Polymorphism Is Associated With the Response to Whole-Cell Pertussis Vaccination in Children From the KOALA Study. Clin Vaccine Immunol; August 15, 2007. [Epub ahead of print].
Rendi-Wagner, P.; Paulke-Korinek, M.; Stanek, G.; Khanakah, G.; Kollaritsch, H. Impact of a Pertussis Booster Vaccination Program in Adolescents and Adults on the Epidemiology of Pertussis in Austria. Pediatr Infect Dis J; 26 (9): 806-810; September, 2007.
Simon, H. B. On Call. Your Article on New Immunizations for Adults Was Very Helpful. I Already Got My Booster for Tetanus, Diphtheria, and Whooping Cough, but Even Though I'm 61, My Doctor Didn't Want to Give Me the Shingles Because I'Ve Already Had Shingles. Should I Get the Vaccine? Harv Mens Health Watch; 11 (12): 8; July, 2007.

Aug 2007

Chan, G. J.; Moulton, L. H.; Becker, S.; Munoz, A.; Black, R. E. Non-Specific Effects of Diphtheria Tetanus Pertussis Vaccination on Child Mortality in Cebu, The Philippines. Int J Epidemiol; July 23, 2007. [Epub ahead of print].
Coudeville, L.; VAN, Rie A.; Andre, P. Adult Pertussis Vaccination Strategies and Their Impact on Pertussis in the United States: Evaluation of Routine and Targeted (Cocoon) Strategies. Epidemiol Infect: 1-17; July 5, 2007.
Viney, K. A.; McAnulty, J. M.; Campbell-Lloyd, S. EPIREVIEW. Pertussis in New South Wales, 1993-2005: the Impact of Vaccination Policy on Pertussis Epidemiology. N S W Public Health Bull; 18 (3-4): 55-61; March, 2007.

Jul 2007

Pertussis Vaccination of Health Care Workers. J Occup Environ Med; 49 (6): 700-702; June, 2007.
Al-Tawfiq, J. A.; Abukhamsin, A. Bordetella Pertussis Infection in a Highly Vaccinated Population in Saudi Arabia, 1996-2004. J Infect; June 11, 2007. [Epub ahead of print].
Goncalves, G.; Santos, M. A.; Frade, J. G.; Cunha, J. S. Levels of Diphtheria and Tetanus Specific IgG of Portuguese Adult Women, Before and After Vaccination With Adult Type Td. Duration of Immunity Following Vaccination. BMC Public Health; 7: 109; June 12, 2007.
Mooi, F. R.; de Greeff, S. C. The Case for Maternal Vaccination Against Pertussis. Lancet Infect Dis; May 28, 2007. [Epub ahead of print].
Riel-Romero, R. M. Acute Transverse Myelitis in a 7-Month-Old Boy After Diphtheria-Tetanus-Pertussis Immunization. Spinal Cord; 45 (6): 463; June, 2007.

Jun 2007

Aaby, P.; Garly, M. L.; Nielsen, J.; Ravn, H.; Martins, C.; Bale, C.; Rodrigues, A.; Benn, C. S.; Lisse, I. M. Increased Female-Male Mortality Ratio Associated With Inactivated Polio and Diphtheria-Tetanus-Pertussis Vaccines: Observations From Vaccination Trials in Guinea-Bissau. Pediatr Infect Dis J. 2007 Mar;26(3):247-52.
Eidlitz-Markus, T.; Mimouni, M.; Zeharia, A. Pertussis Symptoms in Adolescents and Children Versus Infants: The Influence of Vaccination and Age. Clin Pediatr (Phila); May 23, 2007. [Epub ahead of print].
Weber, C. J. Update on Vaccination Against Pertussis. Urol Nurs; 27 (2): 155-156; April, 2007.

May 2007

Edelman, K.; He, Q.; Makinen, J.; Sahlberg, A.; Haanpera, M.; Schuerman, L.; Wolter, J.; Mertsola, J. Immunity to Pertussis 5 Years After Booster Immunization During Adolescence. Clin Infect Dis. 2007 May 15; 44(10):1271-7.
Guiso, N. Impact of Vaccination on the Infectious Diseases Epidemiology: Example of Pertussis. Med Sci (Paris). 2007 Apr; 23 (4): 399-403.
McPartlan, D. Stop Pertussis Too. Nursing2007 Apr;37(4):10.

Apr 2007

Lin, Y. C.; Yao, S. M.; Yan, J. J.; Chen, Y. Y.; Chiang, C. S.; Wu, H. S.; Li, S. Y. Epidemiological Shift in the Prevalence of Pertussis in Taiwan: Implications for Pertussis Vaccination. J Med Microbiol; 56 (Pt 4): 533-537; April, 2007.
Rouzier, R. Prevention: New Whooping Cough Vaccination Guidelines. J Gynecol Obstet Biol Reprod (Paris); March 14, 2007. [Epub ahead of print].

Mar 2007

Cortese, M. M.; Baughman, A. L.; Brown, K.; Srivastava, P. A "New Age" in Pertussis Prevention New Opportunities Through Adult Vaccination. Am J Prev Med; 32 (3): 177-185; March, 2007.
Kummeling, I.; Thijs, C.; Stelma, F.; Huber, M.; van den Brandt, P. A.; Dagnelie, P. C. Diphtheria, Pertussis, Poliomyelitis, Tetanus, and Haemophilus Influenzae Type b Vaccinations and Risk of Eczema and Recurrent Wheeze in the First Year of Life: the KOALA Birth Cohort Study. Pediatrics; 119 (2): e367-e373; February, 2007.
Lee, G. M.; Murphy, T. V.; Lett, S.; Cortese, M. M.; Kretsinger, K.; Schauer, S.; Lieu, T. A. Cost Effectiveness of Pertussis Vaccination in Adults. Am J Prev Med; 32 (3): 186-193; March, 2007.
Mohrenschlager, M.; Haberl, V. M.; Kramer, U.; Behrendt, H.; Ring, J. Early BCG and Pertussis Vaccination and Atopic Diseases in 5- to 7-Year-Old Preschool Children From Augsburg, Germany: Results From the MIRIAM Study. Pediatr Allergy Immunol; 18 (1): 5-9; February, 2007.

Feb 2007

Aaby, P.; Benn, C. S.; Nielsen, J.; Lisse, I. M.; Rodrigues, A.; Jensen, H. DTP Vaccination and Child Survival in Observational Studies With Incomplete Vaccination Data. Trop Med Int Health; 12 (1): 15-24; January, 2007.
David, S. T.; Hemsley, M. C.; Pasquali, P. E.; Larke, B.; Buxton, J. A.; Lior, L. Y. Enhanced Surveillance for Adverse Events Following Immunization: Two Years of DTap Catch-Up Among High School Students in Yukon, Canada (2004, 2005). Can J Public Health; 97 (6): 465-469; November, 2006.
Parkkali, T.; Kayhty, H.; Hovi, T.; Olander, R. M.; Roivainen, M.; Volin, L.; Ruutu, T.; Lahdenkari, M.; Ruutu, P. A Randomized Study on Donor Immunization With Tetanus-Diphtheria, Haemophilus Influenzae Type b and Inactivated Poliovirus Vaccines to Improve the Recipient Responses to the Same Vaccines After Allogeneic Bone Marrow Transplantation. Bone Marrow Transplant; 39 (3): 179-188; February, 2007.
Sanger, R.; Behre, U.; Krause, K. H.; Loch, H. P.; Soemantri, P.; Herrmann, D.; Schmitz-Hauss, E.; Wolter, J.; Hoet, B. Booster Vaccination and 1-Year Follow-Up of 4-8-Year-Old Children With a Reduced-Antigen-Content DTpa-IPV Vaccine. Eur J Pediatr; January 18, 2007. [Epub ahead of print].
You, X.; Kobayashi, Y.; Yang, J.; Zhu, X.; Liang, X. Qualitative Study of Knowledge and Behaviours Related to Tetanus Toxoid Immunization Among Women of Childbearing Age in Rural China. Public Health; January, 2007. [Epub ahead of print].

Jan 2007

Coplu, N.; Esen, B.; Gozalan, A.; Kurtoglu, D.; Ishid, S.; Miyamura, K. Immunity Against Tetanus and Effect of Vaccination in Turkey. Scand J Infect Dis; 38 (11): 1009-1016; 2006.
Frampton, J. E.; Keating, G. M. Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix(Trade Mark)) : A Review of Its Use As a Single-Dose Booster Immunization. BioDrugs; 20 (6): 371-389; 2006.
Guiso, N.; Njamkepo, E.; Vie le, Sage F.; Zepp, F.; Meyer, C. U.; Abitbol, V.; Clyti, N.; Chevallier, S. Long-Term Humoral and Cell-Mediated Immunity After Acellular Pertussis Vaccination Compares Favourably With Whole-Cell Vaccines 6 Years After Booster Vaccination in the Second Year of Life. Vaccine; November 7, 2006. [Epub ahead of print].
Kretsinger, K.; Broder, K. R.; Cortese, M. M.; Joyce, M. P.; Ortega-Sanchez, I.; Lee, G. M.; Tiwari, T.; Cohn, A. C.; Slade, B. A.; Iskander, J. K.; Mijalski, C. M.; Brown, K. H.; Murphy, T. V. Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, Supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel. MMWR Recomm Rep; 55 (RR-17): 1-37; December 15, 2006.

Dec 2006

Brooks, D. A.; Clover, R. Pertussis Infection in the United States: Role for Vaccination of Adolescents and Adults. J Am Board Fam Med; 19 (6): 603-611; November, 2006.
Khan, F. N.; Lin, M.; Hinkle, C. J.; Franklin, P.; Luther, R.; Woodruff, F.; Henson, K.; Lukenbill, M.; Gutierrez, M.; Zhu, B. P. Case-Control Study of Vaccination History in Relation to Pertussis Risk During an Outbreak Among School Students. Pediatr Infect Dis J; 25 (12): 1132-1136; December, 2006.
Southern, J.; Gelb, D.; Andrews, N.; Waight, P. A.; Morris, R.; Cartwright, K.; Miller, E. Reactogenicity of Meningococcal C Conjugate Vaccines When Administered at the Same Time As, or a Month Prior to or After, Tetanus and Diphtheria Booster Vaccinations. Hum Vaccin; 2 (6); November 11, 2006. [Epub ahead of print].
Vickers, D.; Ross, A. G.; Mainar-Jaime, R. C.; Neudorf, C.; Shah, S. Whole-Cell and Acellular Pertussis Vaccination Programs and Rates of Pertussis Among Infants and Young Children. CMAJ; 175 (10): 1213-1217; November 7, 2006.
Wu, S. J.; Sun, S.; Li, J. Y.; Hu, P. Y.; Chien, C. Y. Acute Fulminant Myocarditis After Diphtheria, Polio, and Tetanus Vaccination. Asian Cardiovasc Thorac Ann; 14 (6): e111-e112; December, 2006.

Nov 2006

Elomaa, A.; Advani, A.; Donnelly, D.; Antila, M.; Mertsola, J.; He, Q.; Hallander, H. Population Dynamics of Bordetella Pertussis in Finland and Sweden, Neighbouring Countries With Different Vaccination Histories. Vaccine; September, 2006. [Epub ahead of print].
Frink, M.; Muller, C. W.; Ziesing, S.; Krettek, C. [Tetanus Vaccination in the Accident and Emergency Department.]. Unfallchirurg; October 5, 2006. [Epub ahead of print].
Hitchcock, W. P. Rationale for Use of Tdap Booster Vaccines for Adolescent Immunization: Overview of Efficacy, Safety, and Clinical Use. Clin Pediatr (Phila); 45 (9): 785-794; November, 2006.
Marshall, H. S.; Gold, M. S.; Gent, R.; Quinn, P. J.; Piotto, L.; Clarke, M. F.; Roberton, D. M. Ultrasound Examination of Extensive Limb Swelling Reactions After Diphtheria-Tetanus-Acellular Pertussis or Reduced-Antigen Content Diphtheria-Tetanus-Acellular Pertussis Immunization in Preschool-Aged Children. Pediatrics; 118 (4): 1501-1509; October, 2006.
Middleman, A. B. Immunization Update: Pertussis, Meningoccocus, and Human Papillomavirus. Adolesc Med Clin; 17 (3): 547-563; October, 2006.
Montella, S.; De, Stefano S.; Sperli, F.; Barbarano, F.; Santamaria, F. Increased Risk of Chronic Suppurative Lung Disease After Measles or Pertussis in Non-Vaccinated Children. Vaccine; September 27, 2006. [Epub ahead of print].
Omer, S. B.; Pan, W. K.; Halsey, N. A.; Stokley, S.; Moulton, L. H.; Navar, A. M.; Pierce, M.; Salmon, D. A. Nonmedical Exemptions to School Immunization Requirements: Secular Trends and Association of State Policies With Pertussis Incidence. JAMA; 296 (14): 1757-1763; October 11, 2006.
Pichichero, M.; Papa, T.; Blatter, M.; Mitchell, D.; Kratz, R.; Sneed, J.; Bassily, E.; Casey, J.; Gilmet, G. Immune Memory in Children Previously Vaccinated With an Experimental Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine. Pediatr Infect Dis J; 25 (11): 995-1000; November, 2006.
Pollabauer, E. M.; Petermann, R.; Ehrlich, H. J. Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine: a Meta-Analysis of Immunogenicity, Safety and Posology. Hum Vaccin; 1 (4): 131-139; July, 2005.

Oct 2006

Gustafsson, L.; Hessel, L.; Storsaeter, J.; Olin, P. Long-Term Follow-Up of Swedish Children Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age Indicates the Need for a Booster Dose at 5 to 7 Years of Age. Pediatrics; 118 (3): 978-984; September, 2006.
Kolos, V.; Menzies, R.; McIntyre, P. Higher Pertussis Hospitalization Rates in Indigenous Australian Infants, and Delayed Vaccination. Vaccine; [Epub ahead of print]. August 31, 2006.

Sep 2006

Pertussis Outbreak in an Amish Community--Kent County, Delaware, September 2004-February 2005. MMWR Morb Mortal Wkly Rep; 55 (30): 817-821; August 4, 2006.
Finger, R.; Shoemaker, J. Preventing Pertussis in Infants by Vaccinating Adults. Am Fam Physician; 74 (3): 382; August 1, 2006.
Gentile, D.; Trecki, J.; Patel, A.; Fausnight, T.; Angelini, B.; Skoner, D. Effect of Tetanus Immunization on T-Helper Cytokine Production in Adults With and Without Allergic Rhinitis. Allergy Asthma Proc; 27 (3): 197-201; May, 2006.
Parker, J. Managing Tetanus. Emerg Nurse; 14 (4): 14-17; July, 2006.
Ray, P.; Hayward, J.; Michelson, D.; Lewis, E.; Schwalbe, J.; Black, S.; Shinefield, H.; Marcy, M.; Huff, K.; Ward, J.; Mullooly, J.; Chen, R.; Davis, R. Encephalopathy After Whole-Cell Pertussis or Measles Vaccination: Lack of Evidence for a Causal Association in a Retrospective Case-Control Study. Pediatr Infect Dis J; 25 (9): 768-773; September, 2006.

Aug 2006

Hernan, M. A.; Alonso, A.; Hernandez-Diaz, S. Tetanus Vaccination and Risk of Multiple Sclerosis: a Systematic Review. Neurology; 67 (2): 212-215; July 25, 2006.
Wilson, T. R. Update on Adolescent Immunization: Review of Pertussis and the Efficacy, Safety, and Clinical Use of Vaccines That Contain Tetanus-Diphtheria-Acellular Pertussis. J Pediatr Health Care; 20 (4): 229-237; July, 2006.

Jul 2006

Influence of Genetic and Phenotypical Factors on the Efficiency of the Vaccination of Young Children Against Diphtheria and Measles. Zh Mikrobiol Epidemiol Immunobiol; 2: 42-46; March, 2006.
Ek, T.; Mellander, L.; Hahn-Zoric, M.; Abrahamsson, J. Avidity of Tetanus and Hib Antibodies After Childhood Acute Lymphoblastic Leukaemia - Implications for Vaccination Strategies. Acta Paediatr; 95 (6): 701-706; June, 2006.
Frampton, J. E.; Keam, S. J. Reduced-Antigen, Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine, Adsorbed (Boostrix((R)) US Formulation) : Use As a Single-Dose Booster Immunization in Adolescents Aged 10-18 Years. Paediatr Drugs; 8 (3): 189-195; 2006.
Grilc, E.; Pirnat, N. Pertussis Outbreak in Recently Vaccinated Children in a Kindergarten in Ljubljana During a Resurgence in Pertussis Incidence. Euro Surveill; 10 (8): E050818; August 18, 2005.
Heininger, U.; Cherry, J. D. Pertussis Immunisation in Adolescents and Adults--Bordetella Pertussis Epidemiology Should Guide Vaccination Recommendations. Expert Opin Biol Ther; 6 (7): 685-697; July, 2006.
Lee, J.; Robinson, J. L.; Spady, D. W. Frequency of Apnea, Bradycardia, and Desaturations Following First Diphtheria-Tetanus-Pertussis-Inactivated Polio-Haemophilus Influenzae Type B Immunization in Hospitalized Preterm Infants. BMC Pediatr; 6 (1): 20; June, 2006.
Rishpon, S. Recent Improvements in Polio and Pertussis Vaccination Policy in Israel, 2005. Isr Med Assoc J; 8 (5): 319-321; May, 2006.
Schafer, S.; Gillette, H.; Hedberg, K.; Cieslak, P. A Community-Wide Pertussis Outbreak: An Argument for Universal Booster Vaccination. Arch Intern Med; 166 (12): 1317-1321; June 26, 2006.
Tafaghodi, M.; Jaafari, M. R.; Sajadi Tabassi, S. A. Nasal Immunization Studies Using Liposomes Loaded With Tetanus Toxoid and CpG-ODN. Eur J Pharm Biopharm; May, 2006. [Epub ahead of print].

Jun 2006

Adverse Events After Vaccination With DTap in High School Students Who Have Previously Been Vaccinated With D2T5. Can Commun Dis Rep; 32 (3): 25-28; February 1, 2006.
Diphtheria Vaccine. Wkly Epidemiol Rec; 81 (3): 24-32; January, 2006.
Immunizations. Can Fever-Reducers Prevent Redness From DTP Shots? Child Health Alert; 24 (): 3; April, 2006.
Tetanus Vaccine. Wkly Epidemiol Rec; 81 (20): 198-208; May, 2006.
Cohen, A. L.; Veenstra, D. Economic Analysis of Prevaccination Serotesting Compared With Presumptive Immunization for Polio, Diphtheria, and Tetanus in Internationally Adopted and Immigrant Infants. Pediatrics; 117 (5): 1650-1655; May, 2006.
Sikora, J. P.; Chlebna-Sokol, D.; Ligenza, I.; Sikora, A. Haemophilus Influenzae Type b and Pertussis Vaccinations in Preterm Infants. Arch Immunol Ther Exp (Warsz ); May 2, 2006. [Epub ahead of print].

May 2006

Calvert, J.; Shors, A. R.; Hornung, R. L.; Poorsattar, S. P.; Sidbury, R. Relapse of Wells' Syndrome in a Child After Tetanus-Diphtheria Immunization. J Am Acad Dermatol; 54 (5 Suppl): S232-S233; May, 2006.
Erkek, E.; Tuncez, F.; Sanli, C.; Duman, D.; Kurtipek, G. S.; Bagci, Y.; Ayaslioglu, E. Nicolau's Syndrome in a Newborn Caused by Triple DTP (Diphtheria-Tetanus-Pertussis) Vaccination. J Am Acad Dermatol; 54 (5 Suppl): S241-S242; May, 2006.
Tregnaghi, M.; Lopez, P.; Rocha, C.; Rivera, L.; David, M. P.; Ruttimann, R.; Schuerman, L. A New DTPw-HB/Hib Combination Vaccine for Primary and Booster Vaccination of Infants in Latin America. Rev Panam Salud Publica; 19 (3): 179-188; March, 2006.

Apr 2006

Berrington, J. E.; Cant, A. J.; Matthews, J. N.; O'keeffe, M.; Spickett, G. P.; Fenton, A. C. Haemophilus Influenzae Type b Immunization in Infants in the United Kingdom: Effects of Diphtheria/Tetanus/Acellular Pertussis/Hib Combination Vaccine, Significant Prematurity, and a Fourth Dose. Pediatrics; March, 2006. [Epub ahead of print].
Broder, K. R.; Cortese, M. M.; Iskander, J. K.; Kretsinger, K.; Slade, B. A.; Brown, K. H.; Mijalski, C. M.; Tiwari, T.; Weston, E. J.; Cohn, A. C.; Srivastava, P. U.; Moran, J. S.; Schwartz, B.; Murphy, T. V. Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 55 (RR-3): 1-34; March 24, 2006.
Calugar, A.; Ortega-Sanchez, I. R.; Tiwari, T.; Oakes, L.; Jahre, J. A.; Murphy, T. V. Nosocomial Pertussis: Costs of an Outbreak and Benefits of Vaccinating Health Care Workers. Clin Infect Dis; 42 (7): 981-988; April 1, 2006.
Halperin, S. A.; Sweet, L.; Baxendale, D.; Neatby, A.; Rykers, P.; Smith, B.; Zelman, M.; Maus, D.; Lavigne, P.; Decker, M. D. How Soon After a Prior Tetanus-Diphtheria Vaccination Can One Give Adult Formulation Tetanus-Diphtheria-Acellular Pertussis Vaccine? Pediatr Infect Dis J; 25 (3): 195-200; March, 2006.
Jackson, L. A.; Dunstan, M.; Starkovich, P.; Dunn, J.; Yu, O.; Nelson, J. C.; Rees, T.; Zavitkovsky, A. Prophylaxis With Acetaminophen or Ibuprofen for Prevention of Local Reactions to the Fifth Diphtheria-Tetanus Toxoids-Acellular Pertussis Vaccination: a Randomized, Controlled Trial. Pediatrics; 117 (3): 620-625; March, 2006.
Kochethu, G.; Clark, F. J.; Craddock, C. F. Pertussis: Should We Vaccinate Post Transplant? Bone Marrow Transplant; March 6, 2006. [Epub ahead of print].
Santibanez, T. A.; Santoli, J. M.; Barker, L. E. Differential Effects of the DTaP and MMR Vaccine Shortages on Timeliness of Childhood Vaccination Coverage. Am J Public Health; 96 (4): 691-696; April, 2006.
Valentiner-Branth, P.; Perch, M.; Nielsen, J.; Steinsland, H.; Garly, M. L.; Fischer, T. K.; Sommerfelt, H.; Molbak, K.; Aaby, P. Community Cohort Study of Cryptosporidium Parvum Infections: Sex-Differential Incidences Associated With BCG and Diptheria-Tetanus-Pertussis Vaccinations. Vaccine; February 2, 2006. [Epub ahead of print].

Mar 2006

Galanis, E.; King, A. S.; Varughese, P.; Halperin, S. A. Changing Epidemiology and Emerging Risk Groups for Pertussis. CMAJ; 174 (4): 451-452; February 14, 2006.
Grimprel, E. Whooping Cough in Older Children and Adults. Arch Pediatr; 12 (Spec No 4): 5-7; December, 2005.
Lee, P. Y.; Scumpia, P. O.; Byars, J. A.; Kelly, K. M.; Zhuang, H.; Shuster, J. S.; Theriaque, D. W.; Segal, M. S.; Reeves, W. H.; Brantly, M. L. Short-Term Atorvastatin Treatment Enhances Specific Antibody Production Following Tetanus Toxoid Vaccination in Healthy Volunteers. Vaccine; January 9, 2006. [Epub ahead of print].
Llamas, Urrutia C.; Garcia, Pagador E.; Calderer Cardona, M. R.; Lopez, Martinez R.; Bueno Garcia, M. T.; De la Fuente Cadenas JA Does Anti-Tetanus Vaccination Always Create Protective Immunity?. Rev Enferm; 29 (1): 7-10; January, 2006.
Mitka, M. Age Range Widens for Pertussis Vaccine: Boosters Advised for Adolescents and Adults. JAMA; 295 (8): 871-872; February 22, 2006.

Feb 2006

Whooping Cough Vaccine Approved for Adults. Mayo Clin Health Lett; 23 (10): 4; October, 2005.
Boulay, B. R.; Murray, C. J.; Ptak, J.; Kirkland, K. B.; Montero, J.; Talbot, E. A. An Outbreak of Pertussis in a Hematology-Oncology Care Unit: Implications for Adult Vaccination Policy. Infect Control Hosp Epidemiol; 27 (1): 92-95; January, 2006.
Dabas, P.; Agarwal, C. M.; Kumar, R.; Taneja, D. K.; Ingle, G. K.; Saha, R. Knowledge of General Public and Health Professionals About Tetanus Immunization. Indian J Pediatr; 72 (12): 1035-1037; December, 2005.
Hofmann, F. Environmentally and Occupationally Acquired Diseases in Adolescents and Adulthood: Control of Diphtheria, Tetanus, Pertussis, and Poliomyelitis Through Regular Booster Vaccinations--a European Perspective. Rev Environ Health; 20 (4): 303-317; October, 2005.

Jan 2006

Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep; 54 (50): 1283-1286; December 23, 2005.
Bernsen, R. M.; de Jongste, J. C.; Koes, B. W.; Aardoom, H. A.; van der Wouden, J. C. Diphtheria Tetanus Pertussis Poliomyelitis Vaccination and Reported Atopic Disorders in 8-12-Year-Old Children. Vaccine; November 28, 2005. [Epub ahead of print].
Dominguez, D. The Reemergence of Pertussis in Immunized Populations: a Case Study. Clin Lab Sci; 18 (4): 233-237; 2005.
Knuf, M.; Zepp, F.; Meyer, C.; Grzegowski, E.; Wolter, J.; Riffelmann, M.; Wirsing von Konig, C. H. Immunogenicity of a Single Dose of Reduced-Antigen Acellular Pertussis Vaccine in a Non-Vaccinated Adolescent Population. Vaccine; November 28, 2005. [Epub ahead of print].
Luz, P. M.; Codeco, C. T.; Werneck, G. L.; Struchiner, C. J. A Modelling Analysis of Pertussis Transmission and Vaccination in Rio De Janeiro, Brazil. Epidemiol Infect; November 29, 2005. [Epub ahead of print].
Riel-Romero, R. M. Acute Transverse Myelitis in a 7-Month-Old Boy After Diphtheria-Tetanus-Pertussis Immunization. Spinal Cord; November 29, 2005. [Epub ahead of print].
Vatansever, U.; Coplu, N.; Oner, N.; Sonmez, C.; Karasalihoglu, S.; Kurtoglu, D.; Esen, B.; Ekuklu, G. Seroprevalance of Bordetella Pertussis Antibodies Among Healthy Adolescent Girls in Edirne. Swiss Med Wkly; 135 (35-36): 531-536; September 3, 2005.

Dec 2005

Ohuabunwo, C.; Perevoscikovs, J.; Griskevica, A.; Gargiullo, P.; Brilla, A.; Viksna, L.; Glismann, S.; Wharton, M.; Vitek, C. Respiratory Diphtheria Among Highly Vaccinated Military Trainees in Latvia: Improved Protection From DT Compared With Td Booster Vaccination. Scand J Infect Dis; 37 (11): 813-820; 2005.

Nov 2005

These Shots Aren't Just Kid Stuff. Adults May Soon Be Rolling Up Their Sleeves to Get Vaccinated for Shingles and Whooping Cough. Harv Health Lett; 30 (10): 4-5; August, 2005.
Afridi, N. K.; Hatcher, J.; Mahmud, S.; Nanan, D. Coverage and Factors Associated With Tetanus Toxoid Vaccination Status Among Females of Reproductive Age in Peshawar. J Coll Physicians Surg Pak; 15 (7): 391-395; July, 2005.
Godfroid, F.; Denoel, P.; Poolman, J. Are Vaccination Programs and Isolate Polymorphism Linked to Pertussis Re-Emergence? Expert Rev Vaccines; 4 (5): 757-778; October, 2005.
Hviid, A.; Stellfeld, M.; Wohlfahrt, J.; Andersen, P. H.; Melbye, M. The Impact of Pre-School Booster Vaccination of 4-6-Year-Old Children on Pertussis in 0-1-Year-Old Children. Vaccine; September, 2005. [Epub ahead of print].
Taranger, J. Why Was Whooping Cough Vaccination in Sweden Interrupted Between 1979-1996? Lakartidningen; 102 (39): 2788; September 26, 2005.

Oct 2005

Atabek, M. E.; Pirgon, O. Tetanus in a Fully Immunized Child. J Emerg Med; 29 (3): 345-346; October, 2005.
Baskan, E. B.; Tunali, S.; Kacar, S. D.; Adim, S. B.; Saricaoglu, H. A Case of Granuloma Annulare in a Child Following Tetanus and Diphtheria Toxoid Vaccination. J Eur Acad Dermatol Venereol; 19 (5): 639-640; September, 2005.
Carlsson, R. M.; Ekholm, L.; Gothefors, L.; Granstrom, M.; Trolin, I.; Tegnell, A. Time for Booster Doses Against Whooping Cough for 10-Year-Old Children. Lakartidningen; 102 (35): 2394-2398; August 29, 2005.
Colombet, I.; Saguez, C.; Sanson-Le Pors, M. J.; Coudert, B.; Chatellier, G.; Espinoza, P. Diagnosis of Tetanus Immunization Status: Multicenter Assessment of a Rapid Biological Test. Clin Diagn Lab Immunol; 12 (9): 1057-1062; September, 2005.
Tassignon, J.; Burny, W.; Dahmani, S.; Zhou, L.; Stordeur, P.; Byl, B.; De, Groote D. Monitoring of Cellular Responses After Vaccination Against Tetanus Toxoid: Comparison of the Measurement of IFN-Gamma Production by ELISA, ELISPOT, Flow Cytometry and Real-Time PCR. J Immunol Methods; 35 (2): 188-198; September 9, 2005.

Sep 2005

Greenberg, D. P. Pertussis in Adolescents: Increasing Incidence Brings Attention to the Need for Booster Immunization of Adolescents. Pediatr Infect Dis J; 24 (8): 721-728; August, 2005.
Rota, M. C.; D'Ancona, F.; Massari, M.; Mandolini, D.; Giammanco, A.; Carbonari, P.; Salmaso, S.; Atti, M. L. How Increased Pertussis Vaccination Coverage Is Changing the Epidemiology of Pertussis in Italy. Vaccine; August 17, 2005. [Epub ahead of print]
Southern, J.; Crowley-Luke, A.; Borrow, R.; Andrews, N.; Miller, E. Immunogenicity of One, Two or Three Doses of a Meningococcal C Conjugate Vaccine Conjugated to Tetanus Toxoid, Given As a Three-Dose Primary Vaccination Course in UK Infants at 2, 3 and 4 Months of Age With Acellular Pertussis-Containing DTP/Hib Vaccine. Vaccine; August 17, 2005. [Epub ahead of print]

Aug 2005

Hallander, H. O.; Gustafsson, L.; Ljungman, M.; Storsaeter, J. Pertussis Antitoxin Decay After Vaccination With DTPa Response to a First Booster Dose 312-612 Years After the Third Vaccine Dose. Vaccine; July 25, 2005. [Epub ahead of print]
van Boven, M.; Mooi, F. R.; Schellekens, J. F.; de Melker, H. E.; Kretzschmar, M. Pathogen Adaptation Under Imperfect Vaccination: Implications for Pertussis. Proc Biol Sci; 272 (1572): 1617-1624; August 7, 2005.

Jul 2005

Broutin, H.; Guegan, J. F.; Elguero, E.; Simondon, F.; Cazelles, B. Large-Scale Comparative Analysis of Pertussis Population Dynamics: Periodicity, Synchrony, and Impact of Vaccination. Am J Epidemiol; 161 (12): 1159-1167; June 15, 2005.
Castro, L.; Goncalves, G.; Catarino, J. Reported Cases of Tetanus in the North of Portugal (1993-2002). Missed Opportunities for Vaccination. Acta Med Port; 17 (3): 225-230; May, 2004.
Edwards, K. M. Overview of Pertussis: Focus on Epidemiology, Sources of Infection, and Long Term Protection After Infant Vaccination. Pediatr Infect Dis J; 24 (6 Suppl): S104-S108; June, 2005.
Girard, D. Z. The Cost of Epidemiological Transition: A Study of a Decrease in Pertussis Vaccination Coverage. Health Policy; June 9, 2005. [Epub ahead of print]
Hallander, H. O.; Advani, A.; Donnelly, D.; Gustafsson, L.; Carlsson, R. M. Shifts of Bordetella Pertussis Variants in Sweden From 1970 to 2003, During Three Periods Marked by Different Vaccination Programs. J Clin Microbiol; 43 (6): 2856-2865; June, 2005.
Hay, J. W.; Ward, J. I. Economic Considerations for Pertussis Booster Vaccination in Adolescents. Pediatr Infect Dis J; 24 (6 Suppl): S127-S133; June, 2005.
Lee, G. M.; Lebaron, C.; Murphy, T. V.; Lett, S.; Schauer, S.; Lieu, T. A. Pertussis in Adolescents and Adults: Should We Vaccinate? Pediatrics; 115 (6): 1675-1684; June, 2005.
Pepersack, T.; Turneer, M.; De, Breucker S.; Stubbe, M.; Beyer, I. Tetanus Immunization Among Geriatric Hospitalized Patients. Eur J Clin Microbiol Infect Dis; June 16, 2005. [Epub ahead of print]
Thind, A. Determinants of Tetanus Toxoid Immunization in Pregnancy in Rural Bihar. Trop Doct; 35 (2): 75-77; April, 2005.
van Amersfoorth, S. C.; Schouls, L. M.; van der Heide, H. G.; Advani, A.; Hallander, H. O.; Bondeson, K.; von Konig, C. H.; Riffelmann, M.; Vahrenholz, C.; Guiso, N.; Caro, V.; Njamkepo, E.; He, Q.; Mertsola, J.; Mooi, F. R. Analysis of Bordetella Pertussis Populations in European Countries With Different Vaccination Policies. J Clin Microbiol; 43 (6): 2837-2843; June, 2005.

Jun 2005

Booy, R.; Haworth, E. A.; Ali, K. A.; Chapel, H. M.; Moxon, E. R. Immunogenicity of Routine Vaccination Against Diphtheria, Tetanus, and Haemophilus Influenzae Type b in Asian Infants Born in the United Kingdom. Arch Dis Child; 90 (6): 589-591; June, 2005.
Caro, J. J.; Getsios, D.; El-Hadi, W.; Payne, K.; O'Brien, J. A. Pertussis Immunization of Adolescents in the United States: an Economic Evaluation. Pediatr Infect Dis J; 24 (5 Suppl): S75-S82; May, 2005.
Caro, J. J.; Getsios, D.; Payne, K.; Annemans, L.; Neumann, P. J.; Trindade, E. Economic Burden of Pertussis and the Impact of Immunization. Pediatr Infect Dis J; 24 (5 Suppl): S48-S54; May, 2005.
Claesson, B. A.; Trollfors, B.; Lagergard, T.; Knutsson, N.; Schneerson, R.; Robbins, J. B. Antibodies Against Haemophilus Influenzae Type b Capsular Polysaccharide and Tetanus Toxoid Before and After a Booster Dose of the Carrier Protein Nine Years After Primary Vaccination With a Protein Conjugate Vaccine. Pediatr Infect Dis J; 24 (5): 463-464; May, 2005.
de Greeff, S. C.; Schellekens, J. F.; Mooi, F. R.; de Melker, H. E. Effect of Vaccination Against Pertussis on the Incidence of Pertussis in The Netherlands, 1996-2003. Ned Tijdschr Geneeskd; 149 (17): 937-943; April 23, 2005.
Ercan, T. E.; Soycan, L. Y.; Apak, H.; Celkan, T.; Ozkan, A.; Akdenizli, E.; Kasapcopur, O.; Yildiz, I. Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol; 27 (5): 273-277; May, 2005.
Forsyth, K.; Nagai, M.; Lepetic, A.; Trindade, E. Pertussis Immunization in the Global Pertussis Initiative International Region: Recommended Strategies and Implementation Considerations. Pediatr Infect Dis J; 24 (5 Suppl): S93-S97; May, 2005.
Grimprel, E.; von, Sonnenburg F.; Sanger, R.; Abitbol, V.; Wolter, J. M.; Schuerman, L. M. Combined Reduced-Antigen-Content Diphtheria-Tetanus-Acellular Pertussis and Polio Vaccine (DTpa-IPV) for Booster Vaccination of Adults. Vaccine; 23 (28): 3657-3667; May 25, 2005.
Narkeviciute, I.; Kavaliunaite, E.; Bernatoniene, G.; Eidukevicius, R. Clinical Presentation of Pertussis in Fully Immunized Children in Lithuania. BMC Infect Dis; 5 (1): 40; May 27, 2005. [Epub ahead of print]
Schellekens, J.; von Konig, C. H.; Gardner, P. Pertussis Sources of Infection and Routes of Transmission in the Vaccination Era. Pediatr Infect Dis J; 24 (5 Suppl): S19-S24; May, 2005.
Tan, T.; Halperin, S.; Cherry, J. D.; Edwards, K.; Englund, J. A.; Glezen, P.; Greenberg, D.; Rothstein, E.; Skowronski, D. Pertussis Immunization in the Global Pertussis Initiative North American Region: Recommended Strategies and Implementation Considerations. Pediatr Infect Dis J; 24 (5 Suppl): S83-S86; May, 2005.
Wendelboe, A. M.; Van, Rie A.; Salmaso, S.; Englund, J. A. Duration of Immunity Against Pertussis After Natural Infection or Vaccination. Pediatr Infect Dis J; 24 (5 Suppl): S58-S61; May, 2005.
Wirsing von Konig, C. H.; Campins-Marti, M.; Finn, A.; Guiso, N.; Mertsola, J.; Liese, J. Pertussis Immunization in the Global Pertussis Initiative European Region: Recommended Strategies and Implementation Considerations. Pediatr Infect Dis J; 24 (5 Suppl): S87-S92; May, 2005.

May 2005

Jensen, H.; Benn, C. S.; Aaby, P. DTP in Low Income Countries: Improved Child Survival or Survival Bias? BMJ; 330 (7495): 845-846; April 9, 2005.
Nilsson, L.; Faldella, G.; Jacquet, J. M.; Storsaeter, J.; Silfverdal, S. A.; Ekholm, L. A Fourth Dose of DTPa-IPV Vaccine Given to 4-6 Year Old Children in Italy and Sweden Following Primary Vaccination at 3, 5 and 11-12 Months of Age. Scand J Infect Dis; 37 (3): 221-229; 2005.

Apr 2005

Castillo-Febres, O.; Lopez, G.; Ortegal, F.; Estopinan, M.; Casanova-Escalona, L.; Sanchez-Naveda, M.; Decker, M.; Edwards, K. M. Oropharyngeal Carriers in Venezuelan Children in Two Child Care Settings, Vaccinated or Not With Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine (PRP-T). Invest Clin; 46 (1): 15-24; March, 2005.
De, Serres G.; Duval, B. Pertussis Vaccination Beyond Childhood. Lancet; 365 (9464): 1015-1016; March 16, 2005.
Gindi, M.; Oravitz, P.; Sexton, R.; Shpak, M.; Eisenhart, A. Unreliability of Reported Tetanus Vaccination Histories. Am J Emerg Med; 23 (2): 120-122; March, 2005.
Hewlett, E. L.; Edwards, K. M. Clinical Practice. Pertussis--Not Just for Kids. N Engl J Med; 352 (12): 1215-1222; March 24, 2005.

Mar 2005

Granoff, D. M.; Morgan, A.; Welsch, J. A. Persistence of Group C Anticapsular Antibodies Two to Three Years After Immunization With an Investigational Quadrivalent Neisseria Meningitidis-Diphtheria Toxoid Conjugate Vaccine. Pediatr Infect Dis J; 24 (2): 132-136; February, 2005.
Kumar, R.; Taneja, D. K.; Dabas, P.; Ingle, G. K.; Saha, R. Knowledge About Tetanus Immunization Among Doctors in Delhi. Indian J Med Sci; 59 (1): 3-8; January, 2005.

Feb 2005

Diphtheria, Tetanus and Pertussis Vaccine. Nurs Times; 100 (47): 35; November 23, 2004.
Griffiths, U. K.; Wolfson, L. J.; Quddus, A.; Younus, M.; Hafiz, R. A. Incremental Cost-Effectiveness of Supplementary Immunization Activities to Prevent Neonatal Tetanus in Pakistan. Bull World Health Organ; 82 (9): 643-651; September, 2004.
Kuno-Sakai, H.; Kimura, M. Safety and Efficacy of Acellular Pertussis Vaccine in Japan, Evaluated by 23 Years of Its Use for Routine Immunization. Pediatr Int; 46 (6): 650-655; December, 2004.
Saenger, R.; Maechler, G.; Potreck, M.; Zepp, F.; Knuf, M.; Habermehl, P.; Schuerman, L. Booster Vaccination With Hexavalent DTPa-HBV-IPV/Hib Vaccine in the Second Year of Life Is As Safe As Concomitant DTPa-IPV/Hib + HBV Administered Separately. Vaccine; 23 (9): 1135-1143; January, 2005.

Jan 2005

Boyce, T. G.; Weaver, A. L.; St Sauver, J. L.; Woodward-Lee, A. E.; Stancl, J. K.; Park, J. Y.; Jacobsen, S. J.; Jacobson, R. M.; Poland, G. A. Pertussis Vaccination and the Risk of Respiratory Syncytial Virus-Associated Hospitalization. Pediatr Infect Dis J; 23 (10): 897-901; October, 2004.
Forsyth, K. D.; Campins-Marti, M.; Caro, J.; Cherry, J. D.; Greenberg, D.; Guiso, N.; Heininger, U.; Schellekens, J.; Tan, T.; von Konig, C. H.; Plotkin, S. New Pertussis Vaccination Strategies Beyond Infancy: Recommendations by the Global Pertussis Initiative. Clin Infect Dis; 39 (12): 1802-1809; December 15, 2004.
Hasselhorn, H. M.; Hofmann, F.; Nubling, M. Effect of a Diphtheria Booster Vaccination in Adults With a Documented History of an Incomplete Primary Series Vaccination. Infection; 32 (5): 282-286; October, 2004.

Dec 2004

Cheuvart, B.; Burgess, M.; Zepp, F.; Mertsola, J.; Wolter, J.; Schuerman, L. Anti-Diphtheria Antibody Seroprotection Rates Are Similar 10 Years After Vaccination With DTpa or DTPa Using a Mathematical Model. Vaccine. 23 (3): 336-342; December 2, 2004.
McCall, B. J.; Davison, R. P.; Nissen, M. D.; Nourse, C. B. Pertussis Vaccination for New Parents? Med J Aust. 181 (10): 578; November 15, 2004.
McIntyre, P. B.; Turnbull, F. M.; Egan, A. M.; Burgess, M. A.; Wolter, J. M.; Schuerman, L. M. High Levels of Antibody in Adults Three Years After Vaccination With a Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine. Vaccine. 23 (3): 380-385; December 2, 2004.
Skowronski, D. M.; Pielak, K.; Remple, V. P.; Halperin, B. A.; Patrick, D. M.; Naus, M.; McIntyre, C. Adult Tetanus, Diphtheria and Pertussis Immunization: Knowledge, Beliefs, Behavior and Anticipated Uptake. Vaccine. 23 (3): 353-361; December 2, 2004.
Southern, J.; Deane, S.; Ashton, L.; Borrow, R.; Goldblatt, D.; Andrews, N.; Balmer, P.; Morris, R.; Kroll, J. S.; Miller, E. Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults. Clin Diagn Lab Immunol. 11 (6): 1100-1104; November, 2004.

Nov 2004

Broutin, H.; Simondon, F.; Guegan, J. F. Whooping Cough Metapopulation Dynamics in Tropical Conditions: Disease Persistence and Impact of Vaccination. Proc.R.Soc.Lond B Biol.Sci. 271 Suppl 5:S302-5; August 7, 2004.
Franco, E.; Giambi, C.; Ialacci, R.; Maurici, M. Pertussis Vaccination for Adolescents and Adults. Expert.Opin.Biol.Ther. 4 (10): 1669-1676; October, 2004.
Mari, A. Is There a Causative Role for Tetanus Toxoid Vaccination in the Development of Allergy-Like Symptoms and in the Increasing Prevalence of Atopic Diseases? Med.Hypotheses. 63 (5): 875-886; 2004.
Perriol, M. P.; Devos, D.; Hurtevent, J. F.; Gautier, S.; Caron, J.; Destee, A. Flaccid Tetraplegia Following Anti-Tetanus Vaccination. Rev.Neurol.(Paris). 160 (10): 942-944; October, 2004.

Oct 2004

Chopra, A.; Drage, L. A.; Hanson, E. M.; Touchet, N. L. Stevens-Johnson Syndrome After Immunization With Smallpox, Anthrax, and Tetanus Vaccines. Mayo Clin.Proc.79 (9): 1193-1196; September, 2004.
Hahn, B. J.; Erogul, M.; Sinert, R. Case Report of Tetanus in an Immunized, Healthy Adult and No Point of Entry. J.Emerg.Med.27 (3): 257-260; October, 2004.
Knuf, M.; Schmitt, H. J.; Mohnike, K.; Zepp, F.; Habermehl, P.; Kampmann, C.; Herden, P. Tolerability of the Biken Acellular Pertussis Vaccine in Adults With or Without Previous Vaccination Against Pertussis in Childhood. Med.Klin.(Munich).99 (9): 495-499; September 15, 2004.
Thwaites, C. L.; Yen, L. M.; Nga, N. T.; Parry, J.; Binh, N. T.; Loan, H. T.; Thuy, T. T.; Bethell, D.; Parry, C. M.; White, N. J.; Day, N. P.; Farrar, J. J. Impact of Improved Vaccination Programme and Intensive Care Facilities on Incidence and Outcome of Tetanus in Southern Vietnam, 1993-2002. Trans.R.Soc.Trop.Med.Hyg.98 (11): 671-677; November, 2004.

Sep 2004

Colgrove, J. The Power of Persuasion: Diphtheria Immunization, Advertising, and the Rise of Health Education. Public Health Rep. 119 (5): 506-509; September, 2004.
Edelman, K. J.; He, Q.; Makinen, J. P.; Haanpera, M. S.; Nguyen Tran, Minh N.; Schuerman, L.; Wolter, J.; Mertsola, J. A. Pertussis-Specific Cell-Mediated and Humoral Immunity in Adolescents 3 Years After Booster Immunization With Acellular Pertussis Vaccine. Clin.Infect.Dis. 39 (2): 179-185; July 15, 2004.
Hviid, A.; Stellfeld, M.; Andersen, P. H.; Wohlfahrt, J.; Melbye, M. Impact of Routine Vaccination With a Pertussis Toxoid Vaccine in Denmark. Vaccine. 22 (27-28): 3530-3534; September 9, 2004.

Aug 2004

Le, T.; Cherry, J. D.; Chang, S. J.; Knoll, M. D.; Lee, M. L.; Barenkamp, S.; Bernstein, D.; Edelman, R.; Edwards, K. M.; Greenberg, D.; Keitel, W.; Treanor, J.; Ward, J. I. Immune Responses and Antibody Decay After Immunization of Adolescents and Adults With an Acellular Pertussis Vaccine: the APERT Study. J.Infect.Dis. 190 (3): 535-544; August 1, 2004.
McIntyre, P. Vaccines for Other Neonatal Infections: Vaccination Strategies for the Prevention of Neonatal Pertussis. Expert.Rev.Vaccines. 3 (4): 375-378; August, 2004.
Pfister, R. E.; Aeschbach, V.; Niksic-Stuber, V.; Martin, B. C.; Siegrist, C. A. Safety of DTaP-Based Combined Immunization in Very-Low-Birth-Weight Premature Infants: Frequent but Mostly Benign Cardiorespiratory Events. J.Pediatr. 145 (1): 58-66; July, 2004.
Scuffham, P. A.; McIntyre, P. B. Pertussis Vaccination Strategies for Neonates-an Exploratory Cost-Effectiveness Analysis. Vaccine. 22 (21-22): 2953-2964; July 29, 2004.
Texier, S.; Dermu, M. Tetanus in a Man Presenting With a Chronic Wound. Presse Med. 33 (11): 759-760; June, 2004.

Jul 2004

Hamidon, B. B.; Raymond, A. A. Acute Disseminated Encephalomyelitis (ADEM) Presenting With Seizures Secondary to Anti-Tetanus Toxin Vaccination. Med.J.Malaysia. 58 (5): 780-782; December, 2003.
Jick, H.; Kaye, J. A. Autism and DPT Vaccination in the United Kingdom. N.Engl.J.Med. 350 (26): 2722-2723; June 24, 2004.
Kalaca, S.; Yalcin, M.; Simsek, Yavuz S. Missed Opportunities for Tetanus Vaccination in Pregnant Women, and Factors Associated With Seropositivity. Public Health. 118 (5): 377-382; July, 2004.
Wharton, M. Prevention of Pertussis Among Adolescents by Vaccination: Taking Action on What We Know and Acknowledging What We Do Not Know. Clin.Infect.Dis. 39 (1): 29-30; July 1, 2004.

Jun 2004

Hethcote, H. W.; Horby, P.; McIntyre, P. Using Computer Simulations to Compare Pertussis Vaccination Strategies in Australia. Vaccine.22 (17-18): 2181-2191; June 2, 2004.
Okada, K.; Ueda, K.; Morokuma, K.; Kino, Y.; Tokugawa, K.; Nishima, S. Seroepidemiologic Study on Pertussis, Diphtheria, and Tetanus in the Fukuoka Area of Southern Japan: Seroprevalence Among Persons 0-80 Years Old and Vaccination Program. Jpn.J.Infect.Dis.57 (2): 67-71; April, 2004.

May 2004

Langue, J.; Matisse, N.; Pacoret, P.; Undreiner, F.; Boisnard, F.; Soubeyrand, B. Persistence of Antibodies at 5-6 Years of Age for Children Who Had Received a Primary Series Vaccination With a Pentavalent Whole-Cell Pertussis Vaccine and a First Booster With a Pentavalent Acellular Pertussis Vaccine: Immunogenicity and Tolerance of Second Booster With a Tetravalent Acellular Vaccine at 5-6 Years of Age. Vaccine.22 (11-12): 1406-1414; March 29, 2004.
Mallet, E.; Matisse, N.; Mathieu, N.; Langue, J.; Boisnard, F.; Soubeyrand, B. Antibody Persistence Against Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus Influenzae Type b (Hib) in 5-6-Year-Old Children After Primary Vaccination and First Booster With a Pentavalent Combined Acellular Pertussis Vaccine: Immunogenicity and Tolerance of a Tetravalent Combined Acellular Pertussis Vaccine Given As a Second Booster. Vaccine.22 (11-12): 1415-1422; March 29, 2004.
Nookala, S.; Srinivasan, S.; Kaliraj, P.; Narayanan, R. B.; Nutman, T. B. Impairment of Tetanus-Specific Cellular and Humoral Responses Following Tetanus Vaccination in Human Lymphatic Filariasis. Infect.Immun.72 (5): 2598-2604; May, 2004.
Parlato, A.; Marinelli, A.; Alfieri, R.; Albano, L.; Liguori, G. The Tetanus in Italy and in the Campania Region: Retrospective Analysis. The Importance of Vaccinations. Ig Sanita Pubbl.59 (6): 383-392; November, 2003.
Zielinski, A.; Rosinska, M.; Czarkowski, M.; Rudowska, J. The Effectiveness of Vaccination With Whole-Cell Pertussis Vaccine by Age Group in Poland 1996-2001. Scand.J.Infect.Dis.36 (2): 114-118; 2004.

Apr 2004

School-Associated Pertussis Outbreak--Yavapai County, Arizona, September 2002-February 2003. MMWR Morb.Mortal.Wkly.Rep. 53 (10): 216-219; March, 2004.
Maitra, A.; Sherriff, A.; Griffiths, M.; Henderson, J.; Avon Longitudinal Study Of Parents And Children Study Team Pertussis Vaccination in Infancy and Asthma or Allergy in Later Childhood: Birth Cohort Study. BMJ. March, 2004. [Epub ahead of print].

Mar 2004

Cherry, J. D.; Xing, D. X.; Newland, P.; Patel, K.; Heininger, U.; Corbel, M. J. Determination of Serum Antibody to Bordetella Pertussis Adenylate Cyclase Toxin in Vaccinated and Unvaccinated Children and in Children and Adults With Pertussis. Clin.Infect.Dis. 38 (4): 502-507; February 15, 2004.

Jan 2004

Bernsen, R. M.; de Jongste, J. C.; van der Wouden, J. C. Lower Risk of Atopic Disorders in Whole Cell Pertussis-Vaccinated Children. Eur Respir J. 22 (6): 962-964; December, 2003.
Nilsson, L.; Kjellman, N. I.; Bjorksten, B. Allergic Disease at the Age of 7 Years After Pertussis Vaccination in Infancy: Results From the Follow-Up of a Randomized Controlled Trial of 3 Vaccines. Arch Pediatr Adolesc.Med. 157 (12): 1184-1189; December, 2003.
Skowronski, D. M.; Remple, V. P.; Macnabb, J.; Pielak, K.; Patrick, D. M.; Halperin, S. A.; Scheifele, D. Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact. Pediatrics. 112 (6 Pt 1): e453; December, 2003.
Tanaka, M.; Vitek, C. R.; Pascual, F. B.; Bisgard, K. M.; Tate, J. E.; Murphy, T. V. Trends in Pertussis Among Infants in the United States, 1980-1999. JAMA. 290 (22): 2968-2975; December 10, 2003.

Dec 2003

Dilber, E.; Karagoz, T.; Aytemir, K.; Ozer, S.; Alehan, D.; Oto, A.; Celiker, A. Acute Myocarditis Associated With Tetanus Vaccination. Mayo Clin Proc. 78 (11): 1431-1433; November, 2003.
Tozzi, A. E.; Rava, L.; Ciofi degli Atti, M. L.; Salmaso, S. Clinical Presentation of Pertussis in Unvaccinated and Vaccinated Children in the First Six Years of Life. Pediatrics. 112 (5): 1069-1075; November, 2003.

Nov 2003

Mercier, E.; Serie, M.; Gissot, V.; Dequin, P. F. Tetanus Vaccination. Re-Vaccination Is Necessary but Not Always Sufficient. Presse Med. 32 (30): 1418; September, 2003.

Oct 2003

Paranavithana, S.; Gunasekera, D. P. A Case of Kawasaki Disease With Reaction at a DPT Vaccination Scar Site. Ceylon Med J. 48 (2): 62; June, 2003.
Preziosi, M. P.; Halloran, M. E. Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity. Clin Infect Dis. 37 (6): 772-779; September 15, 2003.
Swartz, T. A.; Saliou, P.; Catznelson, E.; Blondeau, C.; Gil, I.; Peled, T.; Havkin, O.; Fletcher, M. Immune Response to a Diphtheria and Tetanus Toxoid Administration in a Three-Dose Diphtheria Tetanus Whole-Cell Pertussis/Enhanced Inactivated Poliovirus Vaccination Schedule: A 7-Year Follow Up. Eur J Epidemiol. 18 (8): 827-833; 2003.

Sep 2003

One on One. Can I Get Whooping Cough Even If I Was Vaccinated As a Child? Mayo Clin Womens Healthsource. 4 (10): 8; October 2000.
Korobeinikov, A.; Maini, P. K.; Walker, W. J. Estimation of Effective Vaccination Rate: Pertussis in New Zealand As a Case Study. J Theor.Biol. 224 (2): 269-275; September 21, 2003.
Lloyd, J. C.; Haber, P.; Mootrey, G. T.; Braun, M. M.; Rhodes, P. H.; Chen, R. T. Adverse Event Reporting Rates Following Tetanus-Diphtheria and Tetanus Toxoid Vaccinations: Data From the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine. 21 (25-26): 3746-3750; September 8, 2003.

Jul 2003

Brotherton, J.; McAnulty, J. A Pertussis Epidemic in NSW: How Epidemiology Reflects Vaccination Policy. N.S W.Public Health Bull. 14 (4-5): 77-81; April 2003.

Jun 2003

Cotter, B., Bremer, V., Stroh, G., Msambichaka, K., Mabuzane, E., Munyoro, M., Shirehwa, F., Biellik, R., and Birmingham, M. Assessment of Neonatal Tetanus Elimination in an African Setting by Lot Quality Assurance Cluster Sampling (LQA-CS). Epidemiol Infect. 2003, 130 (2): 221-226.

May 2003

Giammanco, A., Taormina, S., Chiarini, A., Dardanoni, G., Stefanelli, P., Salmaso, S., and Mastrantonio, P. Analogous IgG Subclass Response to Pertussis Toxin in Vaccinated Children, Healthy or Affected by Whooping Cough. Vaccine 5-16-2003, 21 (17-18): 1924-1931.
Preziosi, M. P. and Halloran, M. E. Effects of Pertussis Vaccination on Transmission: Vaccine Efficacy for Infectiousness. Vaccine 5-16-2003, 21 (17-18): 1853-1861.
Torvaldsen, S., Simpson, J. M., and McIntyre, P. B. Effectiveness of Pertussis Vaccination in New South Wales, Australia, 1996-1998. Eur.J Epidemiol. 2003, 18 (1): 63-69.

Apr 2003

Hallander, H. O. and Olin, P. Marked Decline in Pertussis Followed Reintroduction of Pertussis Vaccination in Sweden. Euro.Surveill 1999, 4 (12): 128-129.
Osborne, K., Valenciano, M., Veldhuijzen, I., Levy-Bruhl, D., and Pebody, R. ESEN : A Comparison of Vaccination Programmes Part One: Diphtheria. Euro.Surveill 1998, 3 (10): 93-96.
Osborne, K., Valenciano, M., Veldhuijzen, I., Levy-Bruhl, D., and Pebody, R. ESEN : A Comparison of Vaccination Programmes Part Two : Pertussis. Euro.Surveill 1998, 3 (11): 107-110.

Mar 2003

Korang, K., Ghohestani, R., Krieg, T., Uitto, J., and Hunzelmann, N. Exacerbation of Pemphigus Foliaceus After Tetanus Vaccination Accompanied by Synthesis of Auto-Antibodies Against Paraneoplastic Pemphigus Antigens Acta Derm.Venereol. 2002, 82 (6): 482-483.

Dec 2002

Izurieta, H. S., Sutter, R. W., Strebel, P. M., Bardenheier, B., Prevots, D. R., Wharton, M., and Hadler, S. C. Tetanus Surveillance--United States, 1991-1994 MMWR CDC Surveill Summ. 2-21-1997, 46 (2): 15-25
Jonsson, S., Vidarsson, G., Valdimarsson, H., Schiffman, G., Schneerson, R., and Jonsdottir, I. Vaccination of COPD Patients With a Pneumococcus Type 6B Tetanus Toxoid Conjugate Vaccine Eur.Respir.J 2002, 20 (4): 813-818
Lehmann, D., Kakazo, M., Saleu, G., Taime, J., Javati, A., Namuigi, P., Alpers, M. P., Wegmuller, B., Zellmeyer, M., Furer, E., Que, J. U., and Herzog, C. Safety and Immunogenicity of Two Haemophilus Influenzae Type b Polysaccharide-Tetanus Toxoid Conjugate Vaccines (PRP-T) Given With Diphtheria-Tetanus-Pertussis Vaccine to Young Papua New Guinean Children P N.G.Med.J 2001, 44 (1-2): 6-16

Nov 2002

Jonsson, S., Vidarsson, G., Valdimarsson, H., Schiffman, G., Schneerson, R., and Jonsdottir, I. Vaccination of COPD Patients With a Pneumococcus Type 6B Tetanus Toxoid Conjugate Vaccine. Eur.Respir.J 2002, 20 (4): 813-818.

Sep 2002

Cozzani, E., Cacciapuoti, M., Parodi, A., and Rebora, A. Pemphigus Following Tetanus and Diphtheria Vaccination Br.J.Dermatol. 2002, 147 (1): 188-189.

Aug 2002

Whooping Cough Is Still a Problem...Chickenpox Cases Decline When Vaccine Is Used...and a Guide for Parents About Vaccinations Child Health Alert. 2002, 20:1-2. (): 1-2.

Jul 2002

Dvornikov, V. S. Diphtheria in the Republic of North Ossetia (Alania) Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 79-81. [Article in Russian]

Apr 2002

Gold, M. S. Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern? Drug Saf. 2002, 25 (2): 85-90.
Stevenson, M., Beard, S., Finn, A., and Brennan, A. Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule Vaccine. 3-15-2002, 20 (13): 1778-1786.

Mar 2002

Pertussis--United States, 1997-2000 MMWR CDC Surveill Summ. 2-1-2002, 51 (4): 73-76.
From the Centers for Disease Control and Prevention. Supply diphtheria and tetanus toxoids and acellular pertussis vaccine JAMA. 2-6-2002, 287 (5): 579.
Downes, K. A., Domen, R. E., McCarron, K. F., and Bringelsen, K. A. Acute autoimmune hemolytic anemia following DTP vaccination: report of a fatal case and review of the literature Clin.Pediatr.(Phila). 2001, 40 (6): 355-358.

Feb 2002

Fair, E., Murphy, T. V., Golaz, A., and Wharton, M. Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years Pediatrics. 2002, 109 (1): E2.
Jonville-Bera, A. P., Autret-Leca, E., Barbeillon, F., and Llado, J. P. Relationship between vaccination for diphtheria-tetanus-pertussis +/- Haemophilus influenzae b and sudden infant death before three months of age: a case-control study Arch.Pediatr. 2001, 8 (11): 1272-1273.

Jan 2002

Khetsuriani, N., Bisgard, K., Prevots, D. R., Brennan, M., Wharton, M., Pandya, S., Poppe, A., Flora, K., Dameron, G., and Quinlisk, P. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J 2001; 20(12): 1108-1112.
Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Lagergard, T., Schneerson, R., and Robbins, J. B. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Pediatrics 2001; 108(6): 115.

Dec 2001

Kreft, B., Fischer, A., Kruger, S., Sack, K., Kirchner, H., and Rink, L. The impaired immune response to diphtheria vaccination in elderly chronic hemodialysis patients is related to zinc deficiency Biogerontology. 2000, 1 (1): 61-66.

Nov 2001

Daum, R. S., Zenko, C. E., Given, G. Z., Ballanco, G. A., Parikh, H., and Germino, K. Magnitude of Interference after Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b Capsular Polysaccharide-Tetanus Vaccination Is Related to the Number of Doses Administered J.Infect.Dis. 11-15-2001, 184 (10): 1293-1299.
Garly, M. L., Bale, C., Martins, C. L., Balde, M. A., Hedegaard, K. L., Whittle, H. C., and Aaby, P. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens Vaccine. 11-12-2001, 20 (3-4): 468-474.
Maral, I., Baykan, Z., Aksakal, F. N., Kayikcioglu, F., and Bumin, M. A. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage Public Health. 2001, 115 (5): 359-364.
Talani, P., Nzaba, P., Bolanda, D., Ambedet, A., and Moyen, G. Anti-tetanus vaccination protection on the Kouilou region of Congo-Brazzaville Med.Trop.(Mars.). 2001, 61 (2): 195.

Oct 2001

Juretzko, P., Fabian-Marx, T., Haastert, B., Giani, G., von Kries, R., and Wirsing von Konig, C. H.
Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases Epidemiol.Infect. 2001, 127 (1): 63-71.
Kharabsheh, S., Al Otoum, H., Clements, J., Abbas, A., Khuri-Bulos, N., Belbesi, A., Gaafar, T., and Dellepiane, N. Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan Bull.World Health Organ. 2001, 79 (8): 764-770.
Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Sundh, V., Lagergard, T., Lind-Brandberg, L., Zackrisson, G., White, J., Cicirello, H., Fusco, J., and Robbins, J. B. Mass vaccination of children with pertussis toxoid-decreased incidence in both vaccinated and nonvaccinated persons Clin.Infect.Dis. 10-1-2001, 33 (7): 1004-1010.

Aug 2001

Mooi, F. R., van Loo, I. H., and King, A. J. Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence? Emerg.Infect.Dis. 2001, 7 (3 Suppl): 526-528.

Jul 2001

Dagan, R., Amir, J., Ashkenazi, S., Hardt, K., and Kaufhold, A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination Pediatr.Infect.Dis.J. 2001, 20 (6): 587-592.

Jun 2001

George-Chandy, A., Mielcarek, N., Nordstrom, I., Holmgren, J., and Eriksson, K. Vaccination with Bordetella pertussis-Pulsed Autologous or Heterologous Dendritic Cells Induces a Mucosal Antibody Response In Vivo and Protects against Infection Infect.Immun. 2001, 69 (6): 4120-4124.
Pichichero, M. E., Anderson, E. L., Rennels, M. B., Edwards, K. M., and England, J. A. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four- to six-year-olds Pediatr.Infect.Dis.J. 2001, 20 (4): 427-433.

May 2001

Bonaccorsi G, Papini D, Bonanni P, Lo NA, Comodo N. Effects of a booster dose of tetanus toxoid after different primary courses of vaccination: implications on the use of immune globulin. Ann Ig 2001; 13(1):3-10.

Apr 2001

Nicolay, U., Girgsdies, O. E., Banzhoff, A., Hundt, E., Kondler-Budde, R., Lober, R., Hainz, R., and Jilg, W. Diphtheria antitoxin level 2 years after booster vaccination Wien.Med.Wochenschr. 2000, 150 (22): 435-439.

Dec 2000

Christenson B, Hellstrom U, Sylvan SP, Henriksson L, Granstrom M. Impact of a vaccination campaign on adult immunity to diphtheria. Vaccine 2000 Dec 8;19(9-10):1133-40
Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000 Dec 27;284(24):3145-50
Weingart CL, Keitel WA, Edwards KM, Weiss AA. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults. Infect Immun 2000 Dec;68(12):7175-9

Nov 2000

Araujo, O. O., Forleo-Neto, E., Vespa, G. N., Puccini, R. F., Weckx, L. W., Carvalho, E. S., and Farhat, C. K. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. Vaccine 2000 Sep 15;19(2-3):367-75
Maple, P. A., Jones, C. S., Wall, E. C., Vyseb, A., Edmunds, W. J., Andrews, N. J., and Miller, E. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2000 Sep 15;19(2-3):167-73
Schmitt, H. J., Knuf, M., Ortiz, E., Sanger, R., Uwamwezi, M. C., and Kaufhold, A. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections [see comments] J Pediatr 2000 Sep;137(3):304-12
Singleton, J. A., Greby, S. M., Wooten, K. G., Walker, F. J., and Strikas, R. Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7. Mor Mortal Wkly Rep CDC Surveill Summ 2000 Sep 22;49(9):39-62
Skogen, V., Jenum, P. A., Danilov, E., Korolev, V. N., Halvorsen, D. S., and Sjursen, H. Immunity to diphtheria among children in Northern Norway and North-Western Russia. Vaccine 2000 Sep 15;19(2-3):197-203
Stojanov, S., Liese, J. G., Bendjenana, H., Harzer, E., Barrand, M., Jow, S., Dupuy, M., and Belohradsky, B. H. Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six to nine years of age. Munich Vaccine Study Group. Pediatr Infect Dis J 2000 Jun;19(6):516-21

Oct 2000

D'Argenio, P.; Arigliani, R.; Selvaggi, T. M. ReField evaluation of the clinical effectiveness of vaccines against pertusis, measles, rubella, and mumps [letter]. Vaccine 2000 Jul 1;18(26):2925-6.
de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000 Jul-2000 Aug 31;6(4):348-57.
De Serres G. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine. Can Commun Dis Rep 2000 May 1;26:1-8.
Ekwueme DU, Strebel PM, Hadler SC, Meltzer MI, Allen JW, Livengood JR. Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997. Arch Pediatr Adolesc Med 2000 Aug;154(8):797-803.
Elliman, D.; Bedford, H. Perhaps it is not time to switch from whole cell to acellular pertussis vaccine [letter]. BMJ 2000 Aug 12;321(7258):451-2.
Golaz A, Lance-Parker S, Welty T, Schaefer L, Volmer L, LaFromboise C, Dixon J, Haase T, Kim C, Popovic T, et al. Epidemiology of diphtheria in South Dakota. S D J Med 2000 Jul;53(7):281-5.
Hanlon M, Nambiar R, Kakakios A, McIntyre P, Land M, Devine P. Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-cell pertussis ELISA. Immunol Cell Biol 2000 Jun;78(3):254-8.
Holt PG, Rudin A, Macaubas C, Holt BJ, Rowe J, Loh R, Sly PD. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J Allergy Clin Immunol 2000 Jun;105(6 Pt 1):1117-22.
Klein DL. From pertussis to tuberculosis: what can be learned? Clin Infect Dis 2000 Jun;30 Suppl 3:S302-8.
Leef M, Elkins KL, Barbic J, Shahin RD. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J Exp Med 2000 Jun 5;191(11):1841-52.
Matheson AJ, Goa KL. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection. Paediatr Drugs 2000 Mar-2000 Apr 30;2(2):139-59.
Ryan EJ, Nilsson L, Kjellman N, Gothefors L, Mills KH. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol 2000 Aug;121(2):193-200.
Shohat T, Marva E, Sivan Y, Lerman I, Mates A, Cohen A. Immunologic response to a single dose of tetanus toxoid in older people. J Am Geriatr Soc 2000 Aug;48(8):949-51.
Thomas PF, McIntyre PB, Jalaludin BB. Survey of pertussis morbidity in adults in western Sydney [see comments]. Med J Aust 2000 Jul 17;173(2):74-6.
von der Hardt K, Jungert J, Beck JD, Heininger U. Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents--a retrospective analysis. Vaccine 2000 Jul 1;18(26):2999-3004.

Sep 2000

Kutukculer N, Akil T, Egemen A, Kurugol Z, Aksit S, Ozmen D, Turgan N, Bayindir O, Caglayan S. Adequate immune response to tetanus toxoid and failure of vitamin A and E supplementation to enhance antibody response in healthy children. Vaccine 2000 Jul 1;18(26):2979-84.

Aug 2000

Acellular vaccines for preventing whooping cough in children. Tinnion, O. N. and Hanlon, M. Cochrane Database Syst Rev 2000;(2):CD001478
Arthritis following combined vaccine against diphtheria, polyomyelitis, and tetanus toxoid [see comments] Maillefert, J. F., Tonolli-Serabian, I., Cherasse, A., Demoux, A. L., Tavernier, C., and Piroth, L. Clin Exp Rheumatol 2000 Mar-Apr;18(2):255-6
Booster effect of low doses of tetanus toxoid in elderly vaccinees. Bjorkholm, B., Hagberg, L., Sundbeck, G., and Granstrom, M. Eur J Clin Microbiol Infect Dis 2000 Mar;19(3):195-9
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. Ausiello, C. M., Lande, R., Urbani, F., Di Carlo, B., Stefanelli, P., Salmaso, S., Mastrantonio, P., and Cassone, A. J Infect Dis 2000 Jun;181(6):1989-95
Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. Rennels, M. B., Englund, J. A., Bernstein, D. I., Losonsky, G. A., Anderson, E. L., Pichichero, M. E., Munoz, F. M., and Wolff, M. C. Pediatr Infect Dis J 2000 May;19(5):417-23
Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine. Berstad, A. K., Oftung, F., Korsvold, G. E., Haugen, I. L., Froholm, L. O., Holst, J., and Haneberg, B. Vaccine 2000 May 8;18(22):2323-30
Recrudescence of cutaneous Mycobacterium haemophilum lesions following tetanus immunization. Gibson, M. K., Villano, S. A., Huff, C. A., and Cofrancesco, J. Clin Infect Dis 1999 Apr;28(4):919-20

Jul 2000

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Halperin, S. A., Smith, B., Russell, M., Scheifele, D., Mills, E., Hasselback, P., Pim, C., Meekison, W., Parker, R., Lavigne, P., and Barreto, L. Pediatr Infect Dis J 2000 Apr;19(4):276-83
Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Kerr, J. R. and Matthews, R. C. Eur J Clin Microbiol Infect Dis 2000 Feb;19(2):77-88
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat, C., Thisyakorn, U., Chotpitayasunondh, T., Furer, E., Que, J. U., Hasler, T., and Cryz, S. J. Jr Bull World Health Organ 2000;78(3):364-71

Jun 2000

Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults. Vaccine 4-3-2000 18. (19), 1971-1974
Immunogenicity and tolerance of H. influenzae type b, tetanus toxoid conjugate vaccine given concurrently or in combination. Indian J.Pediatr. 1997 64. (6), 839-847
Pertussis in adolescents and adults [letter]. Can.J.Public Health 2000 91. (1), 73
Role of DPT or TT vaccines after injury or as prophylaxis. Indian Pediatr. 1999 36. (2), 198
Tetanus--death by toxin. Nurs.Times 10-13-1999 95. (41), 47-48
The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth. Southeast Asian J.Trop.Med.Public Health 1998 29. (4), 772-778

May 2000

Armstrong E. Time to switch from whole cell to acellular pertussis vaccines? [letter]. BMJ 2000; 320(7238):875.
Balasanian M, McNabb SJ. Epidemic investigation of diphtheria in the Republic of Armenia, 1990-1996. J Infect Dis 2000; 181 Suppl 1:S69-S72.
Bisgard KM, Rhodes P, Hardy IR, Litkina IL, Filatov NN, Monisov AA et al. Diphtheria toxoid vaccine effectiveness: A case-control study in Russia. J Infect Dis 2000; 181 Suppl 1:S184-S187.
Brennan M, Vitek C, Strebel P, Wattigney W, Bisgard K, Brisgalov S et al. How many doses of diphtheria toxoid are required for protection in adults? Results of a case-control study among 40- to 49-year-old adults in the Russian Federation. J Infect Dis 2000; 181 Suppl 1:S193-S196.
Chen RT, Hardy IR, Rhodes PH, Tyshchenko DK, Moiseeva AV, Marievsky VF. Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union. J Infect Dis 2000; 181 Suppl 1:S178-S183.
Decker MD, Edwards KM. Acellular pertussis vaccines. Pediatr Clin North Am 2000; 47(2):309-335.
Dittmann S, Wharton M, Vitek C, Ciotti M, Galazka A, Guichard S et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 181 Suppl 1:S10-S22.
Filonov VP, Zakharenko DF, Vitek CR, Romanovsky AA, Zhukovski VG. Epidemic diphtheria in Belarus, 1992-1997. J Infect Dis 2000; 181 Suppl 1:S41-S46.
Gelbart M. Whooping cough: how the west was won. Nurs Times 1999; 95(40):52-54.
Glinyenko VM, Abdikarimov ST, Firsova SN, Sagamonjan EA, Kadirova R, Nuorti JP et al. Epidemic diphtheria in the Kyrgyz Republic, 1994-1998. J Infect Dis 2000; 181 Suppl 1:S98-S103.
Golaz A, Hardy IR, Glushkevich TG, Areytchiuk EK, Deforest A, Strebel P et al. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J Infect Dis 2000; 181 Suppl 1:S203-S207.
Golaz A, Hardy IR, Strebel P, Bisgard KM, Vitek C, Popovic T et al. Epidemic diphtheria in the Newly Independent States of the Former Soviet Union: implications for diphtheria control in the United States. J Infect Dis 2000; 181 Suppl 1:S237-S243.
Griskevica A, Ching P, Russo G, Kreysler J. Diphtheria in Latvia, 1986-1996. J Infect Dis 2000; 181 Suppl 1:S60-S64.
Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis 2000; 181 Suppl 1:S116-S120.
Harries AD. Applying advances to the developing world for TB and HIV control. Int J Tuberc Lung Dis 2000; 4(2 Suppl 1):S65-S70.
Hurwitz EL, Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther 2000; 23(2):81-90.
Jogiste A, Ching P, Trei T, Kreysler J. Diphtheria in Estonia, 1991-1996. J Infect Dis 2000; 181 Suppl 1:S65-S68.
Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis 2000; 181 Suppl 1:S110-S115.
Kembabanova G, Askarova J, Ivanova R, Deshevoi S, Vitek C, McNabb SJ. Epidemic investigation of diphtheria, Republic of Kazakhstan, 1990-1996. J Infect Dis 2000; 181 Suppl 1:S94-S97.
Khetsuriani N, Imnadze P, Dekanosidze N. Diphtheria epidemic in the Republic of Georgia, 1993-1997. J Infect Dis 2000; 181 Suppl 1:S80-S85.
Khetsuriani N, Music S, Deforest A, Sutter RW. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis 2000; 181 Suppl 1:S208-S212.
Lewis LS, Hardy I, Strebel P, Tyshchenko DK, Sevalnyev A, Kozlova I. Assessment of vaccination coverage among adults 30-49 years of age following a mass diphtheria vaccination campaign: Ukraine, April 1995. J Infect Dis 2000; 181 Suppl 1:S232-S236.
Magdei M, Melnic A, Benes O, Bukova V, Chicu V, Sohotski V et al. Epidemiology and control of diphtheria in the Republic of Moldova, 1946-1996. J Infect Dis 2000; 181 Suppl 1:S47-S54.
Markina SS, Maksimova NM, Vitek CR, Bogatyreva EY, Monisov AA. Diphtheria in the Russian Federation in the 1990s. J Infect Dis 2000; 181 Suppl 1:S27-S34.
Nekrassova LS, Chudnaya LM, Marievski VF, Oksiuk VG, Gladkaya E, Bortnitska II et al. Epidemic diphtheria in Ukraine, 1991-1997. J Infect Dis 2000; 181 Suppl 1:S35-S40.
Niyazmatov BI, Shefer A, Grabowsky M, Vitek CR. Diphtheria epidemic in the Republic of Uzbekistan, 1993-1996. J Infect Dis 2000; 181 Suppl 1:S104-S109.
Porter RW, Steinglass R, Kaiser J, Olkhovsky P, Rasmuson M, Dzhatdoeva FA et al. Role of health communications in Russia's diphtheria immunization program. J Infect Dis 2000; 181 Suppl 1:S220-S227.
Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Nakashidze R, Murvanidze S et al. Risk factors for diphtheria: a prospective case-control study in the Republic of Georgia, 1995-1996. J Infect Dis 2000; 181 Suppl 1:S121-S129.
Quick ML, Sutter RW, Kobaidze K, Malakmadze N, Strebel PM, Nakashidze R et al. Epidemic diphtheria in the Republic of Georgia, 1993-1996: risk factors for fatal outcome among hospitalized patients. J Infect Dis 2000; 181 Suppl 1:S130-S137.
Ronne T, Valentelis R, Tarum S, Griskevica A, Wachmann CH, Aggerbeck H et al. Immune response to diphtheria booster vaccine in the Baltic states. J Infect Dis 2000; 181 Suppl 1:S213-S219.
Sutter RW, Hardy IR, Kozlova IA, Tchoudnaia LM, Gluskevich TG, Marievsky V et al. Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union. J Infect Dis 2000; 181 Suppl 1:S197-S202.
Tsu V, Tyshchenko DK. Case-control evaluation of an adult diphtheria immunization program in Ukraine. J Infect Dis 2000; 181 Suppl 1:S188-S192.
Usmanov I, Favorov MO, Chorba TL. Universal immunization: the diphtheria control strategy of choice in the Republic of Tajikistan, 1993-1997. J Infect Dis 2000; 181 Suppl 1:S86-S93.
Usonis V, Bakasenas V, Morkunas B, Valentelis R, Ching P, Kreysler J. Diphtheria in Lithuania, 1986-1996. J Infect Dis 2000; 181 Suppl 1:S55-S59.
Vitek CR, Bogatyreva EY, Wharton M. Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis 2000; 181 Suppl 1:S23-S26.
Vitek CR, Velibekov AS. Epidemic diphtheria in the 1990s: Azerbaijan. J Infect Dis 2000; 181 Suppl 1:S73-S79.

Apr 2000

Gust I. Standardisation and licensing of combination vaccines based on DTP. Dev.Biol.Stand. 1999;137-41.
Gyhrs A, Lyngholm E, Larsen SO, Aggerbeck H, Heron I. Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine. Scand.J.Infect.Dis. 1999;579-85.
Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000;1312-9.
Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000;E31.
Kumagai T, Ozaki T, Kamada M, Igarashi C, Yuri K, Furukawa H, Wagatuma K, Chiba S, Sato M, Kojima H, Saito A, Okui T, Yano S. Gelatin-containing diphtheria-tetanus-pertussis (DTP) vaccine causes sensitization to gelatin in the recipients. Vaccine 2000;1555-61.
Lodha R, Dash NR, Kapil A, Kabra SK. Diphtheria in urban slums in north India [letter]. Lancet 2000;204.
Meriste S, Tamm E, Willems P, Lutsar I. Safety and immunogenicity of combined Dtpa-IPV vaccine for primary and booster vaccination. Scand.J.Infect.Dis. 1999;587-91.
Rohani P, Earn DJ, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales [letter]. Lancet 2000;285-6.
Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol.Infect. 1999;403-11.
Vellinga A, Van Damme P, Joossens E, Goossens H. Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ 2000;217.
Vinson DR. Immunisation does not rule out tetanus [letter]. BMJ 2000;383.

Feb 2000

Assa'ad A, Lierl M. Effect of acellular pertussis vaccine on the development of allergic sensitization to environmental allergens in adults. J.Allergy Clin.Immunol. 2000;170-5.
Berstad AK, Holst J, Froholm LO, Haugen IL, Wedege E, Oftung F, Haneberg B. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers. J.Med.Microbiol. 2000;157-63.
DTaP-hepatitis B-poliovirus vaccine (SmithKline Beecham). InfanrixDTPa-HepB-IPV. Drugs R.D. 1999;195-6.
Hib-DTaP vaccine (Wyeth-Lederle). Hib-DTP-acellular vaccine--Wyeth-Lederle, Tetracel. Drugs R.D. 1999;203.
Richmond P, Goldblatt D, Fusco PC, Fusco JD, Heron I, Clark S, Borrow R, Michon F. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 1999;641-6.

Dec 1999

Bergfors E, Trollfors B, Taranger J, ard T, Sundh V, Zackrisson G. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int.J.Infect.Dis. 1999;140-6.
Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin.Infect.Dis. 1999;S112-S117.
Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin.Infect.Dis. 1999;S107-S111.
Cooper PJ, Espinel I, Wieseman M, Paredes W, Espinel M, Guderian RH, Nutman TB. Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect.Immun. 1999;5951-7.
de Melker HE, van den HS, Berbers GA, Nagelkerke NJ, Rumke HC, Conyn-van Spaendonck MA. A population-based study on tetanus antitoxin levels in The Netherlands. Vaccine 1999;100-8.
Fagerberg J, Askelof P, Wigzell H, Mellstedt H. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides. Cell Immunol. 1999;110-21.
Fry M, Edwards G, Taylor A. Tetanus--the silent killer: how safe are you? Aust.Crit Care 1998;82-5.
Gardner P. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations. Clin.Infect.Dis. 1999;S131-S135.
Gold M, Kempe A, Osbourn M. A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in South Australia [letter]. Med.J.Aust. 1999;331-2.
Hallander HO, Gnarpe J, Gnarpe H, Olin P. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand.J.Infect.Dis. 1999;281-6.
Hewlett EL. A commentary on the pathogenesis of pertussis. Clin.Infect.Dis. 1999;S94-S98.
Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin.Infect.Dis. 1999;S118-S123.
Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HG, Heuvelman K, Stefanelli P, Mooi FR. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 1999;2069-75.
Menta R. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps: comments [letter]. Vaccine 1999;1-2.
Orenstein WA. Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccination. Clin.Infect.Dis. 1999;S147-S150.
Robbins JB. Pertussis in adults: introduction. Clin.Infect.Dis. 1999;S91-S93.
Sato H, Sato Y. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan. Clin.Infect.Dis. 1999;S124-S130.
Schneerson R. Similarities between the pathogenesis of and immunity to diphtheria and pertussis: the complex nature of serum antitoxin-induced immunity to these two diseases. Clin.Infect.Dis. 1999;S136-S139.
Shimoni Z, Dobrousin A, Cohen J, Pitlik S. Tetanus in an immunised patient. BMJ 1999;1049.
Smith C, Vyas H. Pertussis is increasing in unimmunised infants: is a change of policy needed? [letter]. Arch.Dis.Child 1999;460.

Top ↑

Vaccine Safety-Related Articles

Td/DTaP/Tdap

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Feb 2011

Jan 2011

Dec 2010

Nov 2010

Oct 2010

Sep 2010

Aug 2010

Jul 2010

Jun 2010

May 2010

Apr 2010

Mar 2010

Feb 2010

Jan 2010

Dec 2009

Nov 2009

Oct 2009

Sep 2009

Aug 2009

Jul 2009

Jun 2009

May 2009

Apr 2009

Mar 2009

Feb 2009

Jan 2009

Dec 2008

Nov 2008

Oct 2008

Sep 2008

Aug 2008

Jul 2008

Jun 2008

May 2008

Apr 2008

Mar 2008

Feb 2008

Jan 2008

Nov 2007

Oct 2007

Sep 2007

Aug 2007

Jul 2007

Jun 2007

May 2007

Apr 2007

Mar 2007

Feb 2007

Jan 2007

Dec 2006

Nov 2006

Oct 2006